https://curecurrent.com/trials/influence-of-high-intensity-exercise-on-insulin-resistance-muscle-contractile-properties-aerobic-capacity-and-body-compo-107437 https://curecurrent.com/trials/stabilometric-assessment-of-balance-recovery-in-persons-with-multiple-sclerosis-107438 https://curecurrent.com/trials/hematopoietic-stem-cell-therapy-for-patients-with-multiple-sclerosis-107439 https://curecurrent.com/trials/natalizumab-de-escalation-with-interferon-beta-1b-107440 https://curecurrent.com/trials/task-oriented-circuit-class-training-in-multiple-sclerosis-subjects-107441 https://curecurrent.com/trials/neuroprotection-with-riluzole-patients-with-early-multiple-sclerosis-107442 https://curecurrent.com/trials/effects-of-targeted-lower-extremity-joint-training-on-multiple-sclerosis-ms-gait-abnormalities-107443 https://curecurrent.com/trials/assessment-of-the-pharmacokinetics-of-circadin-in-children-with-neurodevelopmental-disorders-and-sleep-disturbances-107444 https://curecurrent.com/trials/long-term-prospective-study-evaluating-clinical-and-molecular-biomarkers-of-epileptogenesis-in-a-genetic-model-of-epilep-107445 https://curecurrent.com/trials/effects-of-a-12-week-respiratory-muscles-training-program-in-persons-with-relapsing-remitting-multiple-sclerosis-107446 https://curecurrent.com/trials/combination-therapy-in-patients-with-relapsing-remitting-multiple-sclerosis-ms-combirx-107447 https://curecurrent.com/trials/evaluation-of-the-positron-emission-tomography-pet-tracer-zk-6032924-in-patients-with-multiple-sclerosis-compared-to-hea-107448 https://curecurrent.com/trials/an-efficacy-safety-and-tolerability-study-of-glatiramer-acetate-ga-20-mg-0-5-ml-new-formulation-administered-daily-by-su-107449 https://curecurrent.com/trials/core-stability-training-in-multiple-sclerosis-107450 https://curecurrent.com/trials/a-postmarketing-surveillance-pms-study-to-evaluate-the-extent-to-which-patient-compliance-is-influenced-by-use-of-a-vari-107451 https://curecurrent.com/trials/an-observational-study-of-multiple-sclerosis-ms-patients-starting-or-restarting-baseline-treatment-with-interferon-beta-107452 https://curecurrent.com/trials/a-phase-iia-study-of-nt-ko-003-for-multiple-sclerosis-107453 https://curecurrent.com/trials/a-canadian-study-assessing-the-utility-of-the-treatment-optimization-recommendations-in-multiple-sclerosis-107454 https://curecurrent.com/trials/impact-of-vitamin-a-supplementation-on-immune-system-in-multiple-sclerosis-patients-107455 https://curecurrent.com/trials/safety-and-neuroprotective-effects-of-polyphenon-e-in-ms-phase-ii-107456 https://curecurrent.com/trials/study-of-alemtuzumab-in-treatment-refractory-ms-subjects-alemtuzumab-naive-alemtuzumab-experienced-subjects-107457 https://curecurrent.com/trials/the-rebif-vs-glatiramer-acetate-in-relapsing-multiple-sclerosis-pharmacogenetics-trial-107458 https://curecurrent.com/trials/autologous-t-cell-vaccine-tcv-for-multiple-sclerosis-107459 https://curecurrent.com/trials/a-observational-prospective-study-to-assess-the-impact-of-fatigue-in-the-quality-of-life-of-patients-with-multiple-scler-107460 https://curecurrent.com/trials/a-study-to-evaluate-rituximab-in-adults-with-relapsing-remitting-multiple-sclerosis-107461 https://curecurrent.com/trials/transition-to-rebif-new-formulation-107462 https://curecurrent.com/trials/a-phase-iv-study-of-rebif-44mcg-administered-three-times-per-week-by-subcutaneous-injection-compared-with-no-treatment-i-107463 https://curecurrent.com/trials/study-to-evaluate-the-immunogenicity-and-safety-of-r-hifn-beta-1a-rebif-using-clone-484-39-in-multiple-sclerosis-107464 https://curecurrent.com/trials/simvastatin-as-an-add-on-treatment-to-copaxone-for-the-treatment-of-relapsing-multiple-sclerosis-107465 https://curecurrent.com/trials/tolerability-of-rebif-interferon-beta-1-a-therapy-in-korean-patients-with-multiple-sclerosis-107466 https://curecurrent.com/trials/assessment-of-patient-use-of-a-new-device-rebismart-107467 https://curecurrent.com/trials/an-observational-study-to-assess-the-quality-of-life-of-the-patients-with-multiple-sclerosis-and-their-caregivers-107468 https://curecurrent.com/trials/mesenchymal-stem-cell-transplantation-in-ms-107469 https://curecurrent.com/trials/hydroxyurea-in-primary-progressive-multiple-sclerosis-107470 https://curecurrent.com/trials/a-6-month-randomized-open-label-patient-outcomes-safety-and-tolerability-study-of-fingolimod-fty720-0-5-mg-day-vs-compar-107471 https://curecurrent.com/trials/a-safety-and-efficacy-study-of-oral-cladribine-in-subjects-with-relapsing-remitting-multiple-sclerosis-rrms-107472 https://curecurrent.com/trials/an-observational-retrospective-uk-ireland-audit-of-patient-adherence-to-rebif-injections-using-the-rebismart-injection-d-107473 https://curecurrent.com/trials/assessment-of-subject-use-of-the-rebiject-ii-injection-device-according-to-nurse-examination-of-subject-accuracy-in-10-s-107474 https://curecurrent.com/trials/an-observational-study-to-evaluate-quality-of-life-qol-and-influence-of-cognitive-status-on-qol-in-patients-with-relapsi-107475 https://curecurrent.com/trials/naps-ms-natalizumab-effects-on-parameters-of-sleep-in-patients-with-multiple-sclerosis-experiencing-fatigue-or-sleepines-107476 https://curecurrent.com/trials/rebif-flexible-dosing-in-early-multiple-sclerosis-ms-107477 https://curecurrent.com/trials/natalizumab-de-escalation-to-interferon-beta-1b-in-patients-with-relapsing-remitting-multiple-sclerosis-107478 https://curecurrent.com/trials/comparison-of-bone-effects-with-copaxone-and-interferon-in-multiple-sclerosis-107479 https://curecurrent.com/trials/neurophysiological-study-of-sativex-in-multiple-sclerosis-ms-spasticity-107480 https://curecurrent.com/trials/robot-assisted-gait-training-in-multiple-sclerosis-subjects-107481 https://curecurrent.com/trials/testing-the-efficacy-of-self-generation-treatment-protocol-107482 https://curecurrent.com/trials/assessment-study-of-steroid-effect-in-relapsing-multiple-sclerosis-subjects-treated-with-glatiramer-acetate-107483 https://curecurrent.com/trials/benefit-study-betaferon-betaseron-in-newly-emerging-multiple-sclerosis-for-initial-treatment-and-benefit-follow-up-study-107484 https://curecurrent.com/trials/evaluation-of-emotional-disorders-during-treatment-by-interferon-beta-in-relapsing-remitting-multiple-sclerosis-patients-107485 https://curecurrent.com/trials/minocycline-as-add-on-to-interferon-beta-1a-ifn-beta-1a-rebif-in-relapsing-remitting-multiple-sclerosis-rrms-107486 https://curecurrent.com/trials/a-study-of-the-safety-and-efficacy-of-ono-4641-in-patients-with-relapsing-remitting-multiple-sclerosis-107487 https://curecurrent.com/trials/development-and-evaluation-of-a-cognitive-rehabilitation-program-for-persons-with-multiple-sclerosis-107488 https://curecurrent.com/trials/interest-of-dynamic-measures-of-the-pupil-in-optic-neuritis-107489 https://curecurrent.com/trials/testing-mitochondria-activity-and-blood-lipid-content-of-multiple-sclerosis-patients-107490 https://curecurrent.com/trials/zoledronic-acid-in-ms-patients-with-osteoporosis-107491 https://curecurrent.com/trials/evaluation-of-angioplasty-in-the-treatment-of-chronic-cerebrospinal-venous-insufficiency-ccsvi-in-multiple-sclerosis-107492 https://curecurrent.com/trials/high-dose-chemo-with-stem-cell-transplant-as-treatment-for-multiple-sclerosis-that-failed-prior-treatment-107493 https://curecurrent.com/trials/immune-regulation-in-multiple-sclerosis-microrna-and-antigen-presenting-cells-107494 https://curecurrent.com/trials/12-week-study-to-evaluate-rebismart-suitability-for-self-injection-in-relapsing-multiple-sclerosis-107495 https://curecurrent.com/trials/prospective-open-label-tolerability-and-safety-monitoring-study-of-novantrone-in-a-selected-cohort-of-multiple-sclerosis-107496 https://curecurrent.com/trials/bayer-cognitive-assessments-with-multiple-sclerosis-subjects-107497 https://curecurrent.com/trials/determine-impact-of-multiple-nab-tests-on-treatment-compared-to-usual-care-of-ms-patients-on-high-dose-ifn-therapy-107498 https://curecurrent.com/trials/sodium-intake-in-multiple-sclerosis-107499 https://curecurrent.com/trials/safety-study-in-relapsing-remitting-multiple-sclerosis-rrms-patients-receiving-betaferon-or-rebif-107500 https://curecurrent.com/trials/evaluation-of-two-glatiramer-acetate-ga-formulations-in-relapsing-remitting-multiple-sclerosis-rrms-patients-107501 https://curecurrent.com/trials/to-assess-the-prevalence-of-spasticity-and-the-impact-on-the-quality-of-life-in-multiple-sclerosis-patients-107502 https://curecurrent.com/trials/correlation-between-multiple-sclerosis-functional-composite-msfc-and-expanded-disability-status-scale-edss-in-patients-w-107503 https://curecurrent.com/trials/sexual-dysfunction-disability-and-quality-of-life-in-patients-with-multiple-sclerosis-ms-107504 https://curecurrent.com/trials/impact-of-armodafinil-on-neurocognition-and-cognitive-fatigue-in-multiple-sclerosis-ms-107505 https://curecurrent.com/trials/an-open-label-proof-of-concept-study-to-evaluate-the-effects-of-dalfampridine-withdrawal-on-gait-and-balance-parameters-107506 https://curecurrent.com/trials/anti-inflammatory-type-ii-monocyte-induction-by-glatiramer-acetate-copaxone-treatment-of-multiple-sclerosis-107507 https://curecurrent.com/trials/modafinil-in-multiple-sclerosis-107508 https://curecurrent.com/trials/rad001-therapy-of-angiomyolipomata-in-patients-with-ts-complex-and-sporadic-lam-107509 https://curecurrent.com/trials/phase-3-study-to-evaluate-efficacy-and-safety-of-nu100-in-patients-with-relapsing-remitting-multiple-sclerosis-rrms-107510 https://curecurrent.com/trials/lokomat-training-effects-on-ms-gait-abnormalities-107511 https://curecurrent.com/trials/targeted-lower-extremity-joint-training-107512 https://curecurrent.com/trials/restoration-of-walking-in-multiple-sclerosis-using-treadmill-training-107513 https://curecurrent.com/trials/effect-of-robot-assisted-training-on-foot-drop-in-multiple-sclerosis-107514 https://curecurrent.com/trials/treatment-interruption-of-natalizumab-107515 https://curecurrent.com/trials/long-term-follow-up-for-rad001-therapy-of-angiomyolipomata-in-patients-with-tuberous-sclerosis-tsc-and-sporadic-lymphang-107516 https://curecurrent.com/trials/an-observational-study-for-the-assessment-of-adherence-effectiveness-and-convenience-of-rebif-treatment-in-relapsing-mul-107517 https://curecurrent.com/trials/avonex-safety-and-tolerability-in-chinese-subjects-with-relapsing-multiple-sclerosis-ms-107518 https://curecurrent.com/trials/matrix-measuring-neutralizing-antibodies-in-the-patients-treated-with-interferon-beta-1a-im-in-mexico-and-colombia-107519 https://curecurrent.com/trials/is-ifn-beta-treatment-in-ms-useful-after-a-washout-period-in-patients-with-neutralizing-antibodies-to-interferon-beta-107520 https://curecurrent.com/trials/dose-escalation-study-to-evaluate-the-penetration-and-pharmacodynamic-effects-of-baminercept-in-the-cerebrospinal-fluid-107521 https://curecurrent.com/trials/avonex-pen-satisfaction-and-patients-experience-clinical-trial-107522 https://curecurrent.com/trials/avonex-interferon-beta-1a-and-avonex-plus-methylprednisolone-for-the-treatment-of-relapsing-remitting-ms-107523 https://curecurrent.com/trials/stress-management-for-patients-with-multiple-sclerosis-107524 https://curecurrent.com/trials/post-authorization-observational-study-to-evaluate-cognition-and-fatigue-in-relapsing-remitting-multiple-sclerosis-rrms-107525 https://curecurrent.com/trials/study-of-fampridine-er-tablets-in-patients-with-multiple-sclerosis-107526 https://curecurrent.com/trials/an-extension-study-of-the-efficacy-and-safety-of-fingolimod-fty720-in-patients-with-relapsing-multiple-sclerosis-107527 https://curecurrent.com/trials/telephone-intervention-for-pain-study-tips-107528 https://curecurrent.com/trials/a-multicenter-open-label-randomized-crossover-trial-to-assess-subject-preference-for-kemstro-compared-to-conventional-ba-107529 https://curecurrent.com/trials/a-multinational-randomized-double-blind-parallel-group-placebo-controlled-study-assessing-the-safety-and-tolerability-107530 https://curecurrent.com/trials/the-efficacy-of-vitamin-k2-n-human-osteoporosis-blood-vessel-calcification-and-sclerosis-107531 https://curecurrent.com/trials/validation-of-hand-held-dynamometer-for-assessment-of-lower-limb-muscle-strength-in-multiple-sclerosis-107532 https://curecurrent.com/trials/a-multicenter-open-label-rebismart-autoinjector-ease-of-use-study-107533 https://curecurrent.com/trials/effect-of-i-travle-training-on-arm-function-in-ms-and-chronic-stroke-patients-107534 https://curecurrent.com/trials/rebif-new-formulation-rnf-quality-of-life-qol-study-107535 https://curecurrent.com/trials/rnf-and-betaseron-tolerability-study-107536 https://curecurrent.com/trials/the-multicenter-open-label-single-use-autoinjector-convenience-study-107537 https://curecurrent.com/trials/implementation-study-of-treatment-optimization-recommendations-on-relapsing-remitting-multiple-sclerosis-rr-ms-subjects-107538 https://curecurrent.com/trials/tolerability-of-rebif-injection-with-and-without-the-use-of-rebiject-mini-in-relapsing-remitting-multiple-sclerosis-subj-107539 https://curecurrent.com/trials/rebif-pregnancy-registry-107540 https://curecurrent.com/trials/a-study-of-rebif-compared-with-avonex-in-the-treatment-of-relapsing-remitting-multiple-sclerosis-ms-107541 https://curecurrent.com/trials/a-phase-ii-study-of-orally-administered-bez235-monotherapy-in-patients-with-metastatic-or-unresectable-malignant-pecoma-107542 https://curecurrent.com/trials/comprehensive-analysis-of-relapse-in-multiple-sclerosis-107543 https://curecurrent.com/trials/exercise-in-severely-disabled-patients-with-ms-107544 https://curecurrent.com/trials/cyclic-oral-methylprednisolone-trial-in-multiple-sclerosis-107545 https://curecurrent.com/trials/safety-of-polyphenon-e-in-multiple-sclerosis-pilot-study-107546 https://curecurrent.com/trials/evaluation-of-risk-factors-for-early-termination-of-injection-treatment-with-betaferon-in-patients-suffering-from-multip-107547 https://curecurrent.com/trials/sativex-versus-placebo-when-added-to-existing-treatment-for-central-neuropathic-pain-in-ms-107548 https://curecurrent.com/trials/longitudinal-weekly-follow-up-of-active-plaques-in-multiple-sclerosis-with-3-teslas-multi-modality-mri-using-diffusion-p-107549 https://curecurrent.com/trials/safety-and-efficacy-of-cellcept-and-avonex-as-combination-treatment-in-multiple-sclerosis-107550 https://curecurrent.com/trials/analysis-of-lymphocyte-cell-surface-adhesion-marker-expression-in-natalizumab-population-with-active-control-107551 https://curecurrent.com/trials/improving-new-learning-and-memory-in-multiple-sclerosis-107552 https://curecurrent.com/trials/functional-and-physiological-responses-to-lokomat-therapy-pilot-study-107553 https://curecurrent.com/trials/the-effect-of-anodal-tdcs-on-motor-learning-in-multiple-sclerosis-107554 https://curecurrent.com/trials/avonex-safety-blood-levels-and-effects-107555 https://curecurrent.com/trials/efficacy-of-fish-oil-in-multiple-sclerosis-107556 https://curecurrent.com/trials/investigation-of-gm-pathology-using-ultra-high-field-7t-mri-scanner-107557 https://curecurrent.com/trials/mesenchymal-stem-cells-for-multiple-sclerosis-107558 https://curecurrent.com/trials/occupational-therapy-in-patients-with-multiple-sclerosis-107559 https://curecurrent.com/trials/a-longitudinal-study-of-brain-atrophy-in-ms-patients-over-5-years-107560 https://curecurrent.com/trials/whole-body-vibration-therapy-in-participants-with-ms-related-balance-deficits-107561 https://curecurrent.com/trials/safety-study-of-combination-therapy-with-intramuscular-avonex-and-oral-cellcept-in-patients-with-multiple-sclerosis-107562 https://curecurrent.com/trials/modeling-and-treating-the-pathophysiology-of-demyelination-in-multiple-sclerosis-107563 https://curecurrent.com/trials/continuous-positive-airway-pressure-cpap-for-fatigue-in-patients-with-multiple-sclerosis-ms-and-obstructive-sleep-apnea-107564 https://curecurrent.com/trials/a-longitudinal-study-of-effect-of-copaxone-in-rrms-over-24-months-107565 https://curecurrent.com/trials/the-effects-of-attention-retraining-in-ms-107566 https://curecurrent.com/trials/teleconference-fatigue-management-for-people-with-multiple-sclerosis-107567 https://curecurrent.com/trials/study-evaluating-cci-779-in-relapsing-multiple-sclerosis-107568 https://curecurrent.com/trials/safety-and-immunologic-effect-of-low-dose-versus-high-dose-vitamin-d3-in-multiple-sclerosis-107569 https://curecurrent.com/trials/therapy-optimization-in-multiple-sclerosis-ms-107570 https://curecurrent.com/trials/effects-of-vestibular-rehabilitation-on-ms-related-fatigue-a-randomized-control-trial-107571 https://curecurrent.com/trials/neuroprotection-and-repair-in-optic-neuritis-107572 https://curecurrent.com/trials/management-of-pain-in-persons-with-multiple-sclerosis-107573 https://curecurrent.com/trials/vitamine-d-in-multiple-sclerosis-107574 https://curecurrent.com/trials/safety-and-effectiveness-of-two-doses-of-abt-874-as-compared-to-placebo-in-subjects-with-multiple-sclerosis-ms-107575 https://curecurrent.com/trials/study-of-teriflunomide-in-reducing-the-frequency-of-relapses-and-accumulation-of-disability-in-patients-with-multiple-sc-107576 https://curecurrent.com/trials/long-term-safety-of-teriflunomide-when-added-to-interferon-beta-or-glatiramer-acetate-in-patients-with-multiple-sclerosi-107577 https://curecurrent.com/trials/role-of-vitamin-d-in-reducing-the-relapse-rate-in-patients-with-multiple-sclerosis-107578 https://curecurrent.com/trials/safety-study-of-an-immunomodulating-microparticle-to-treat-progressive-multiple-sclerosis-107579 https://curecurrent.com/trials/the-efficacy-of-emdr-in-patients-with-ptsd-in-multiple-sclerosis-107580 https://curecurrent.com/trials/efficacy-and-safety-of-methylprednisolone-per-os-versus-iv-for-the-treatment-of-multiple-sclerosis-ms-relapses-107581 https://curecurrent.com/trials/randomized-controlled-trial-to-test-the-efficacy-of-interferon-beta-in-the-treatment-of-intermediate-uveitis-107582 https://curecurrent.com/trials/response-to-interferon-alpha-in-interferon-neutralizing-antibody-positive-multiple-sclerosis-patients-107583 https://curecurrent.com/trials/safety-and-efficacy-of-umbilical-cord-mesenchymal-stem-cell-therapy-for-patients-with-progressive-multiple-sclerosis-and-107584 https://curecurrent.com/trials/betaseron-16-year-long-term-follow-up-ltf-in-patients-with-relapsing-remitting-multiple-sclerosis-107585 https://curecurrent.com/trials/demonstrate-the-bioequivalence-of-interferon-beta-1a-infb-manufactured-by-two-different-processes-in-healthy-volunteers-107586 https://curecurrent.com/trials/betaplus-survey-observational-study-to-assess-drug-adherence-in-patients-with-multiple-sclerosis-after-conversion-to-bet-107587 https://curecurrent.com/trials/combination-therapy-using-cellcept-and-rebif-in-rrms-107588 https://curecurrent.com/trials/magnetic-resonance-imaging-mri-follow-up-of-macrophagic-infiltration-in-ms-patients-treated-with-tysabri-107589 https://curecurrent.com/trials/a-study-of-the-pharmacokinetics-and-immunologic-effects-of-lipoic-acid-in-multiple-sclerosis-107590 https://curecurrent.com/trials/phase-ii-study-of-teriflunomide-as-adjunctive-therapy-to-interferon-beta-in-subjects-with-multiple-sclerosis-107591 https://curecurrent.com/trials/phase-ii-study-of-teriflunomide-as-adjunctive-therapy-to-glatiramer-acetate-in-subjects-with-multiple-sclerosis-107592 https://curecurrent.com/trials/portuguese-observational-survey-to-assess-drug-adherence-in-patients-with-multiple-sclerosis-after-conversion-to-betafer-107593 https://curecurrent.com/trials/effect-of-melatonin-on-multiple-sclerosis-related-fatigue-107594 https://curecurrent.com/trials/ginseng-in-treatment-of-fatigue-in-multiple-sclerosis-107595 https://curecurrent.com/trials/impact-of-vitamin-a-on-rar-gene-expression-in-multiple-sclerosis-107596 https://curecurrent.com/trials/safety-and-efficacy-of-teriflunomide-hmr1726-in-multiple-sclerosis-with-relapses-107597 https://curecurrent.com/trials/safety-and-efficacy-study-of-erythropoietin-as-add-on-therapy-of-methylprednisolone-to-treat-acute-optic-neuritis-107598 https://curecurrent.com/trials/motor-training-and-white-matter-in-multiple-sclerosis-ms-107599 https://curecurrent.com/trials/long-term-study-of-fingolimod-in-ms-patients-from-the-fty-clinical-program-107600 https://curecurrent.com/trials/the-effect-of-transcutaneous-electrical-nerve-stimulation-tens-in-multiple-sclerosis-107601 https://curecurrent.com/trials/the-effects-of-interferon-beta-combined-with-vitamin-d-on-relapsing-remitting-multiple-sclerosis-patients-107602 https://curecurrent.com/trials/study-on-cognitive-disorders-of-multiple-sclerosis-107603 https://curecurrent.com/trials/efficacy-and-safety-of-fingolimod-fty720-in-patients-with-relapsing-remitting-multiple-sclerosis-107604 https://curecurrent.com/trials/controlled-high-risk-avonex-multiple-sclerosis-prevention-study-in-ongoing-neurological-surveillance-107605 https://curecurrent.com/trials/early-cognitive-impairment-in-multiple-sclerosis-107606 https://curecurrent.com/trials/experimental-evaluation-of-wheelchair-mounted-robotic-arms-107607 https://curecurrent.com/trials/efficacy-and-safety-evaluation-of-nabilone-as-adjunctive-therapy-to-gabapentin-for-the-management-of-neuropathic-pain-in-107608 https://curecurrent.com/trials/neuropathic-pain-assessment-comparing-pregabalin-and-paroxetine-in-management-of-ms-induced-neuropathic-pain-107609 https://curecurrent.com/trials/impact-of-vitamin-a-on-gene-expression-in-multiple-sclerosis-patient-107610 https://curecurrent.com/trials/long-term-efficacy-and-safety-of-fingolimod-fty720-in-patients-with-relapsing-remitting-multiple-sclerosis-107611 https://curecurrent.com/trials/evaluate-early-glatiramer-acetate-treatment-in-delaying-conversion-to-clinically-definite-multiple-sclerosis-of-subjects-107612 https://curecurrent.com/trials/effect-of-treatment-with-fingolimod-on-the-immune-response-following-seasonal-flu-vaccination-and-tetanus-booster-inject-107613 https://curecurrent.com/trials/the-role-of-serum-leptin-levels-in-multiple-sclerosis-disease-activity-while-on-interferon-beta-1a-rebif-treatment-107614 https://curecurrent.com/trials/a-randomized-exercise-trial-for-wheelchair-users-107615 https://curecurrent.com/trials/immunoregulation-by-controlled-parasite-exposure-in-multiple-sclerosis-107616 https://curecurrent.com/trials/placebo-controlled-study-of-ono2506po-in-the-presence-of-riluzole-in-patients-with-amyotrophic-lateral-sclerosis-als-107617 https://curecurrent.com/trials/a-phase-ii-multi-centre-extension-study-to-investigate-the-long-term-safety-of-ono-2506po-in-patients-diagnosed-with-amy-107618 https://curecurrent.com/trials/memantine-therapy-for-multiple-sclerosis-107619 https://curecurrent.com/trials/physical-activity-and-fatigue-in-early-multiple-sclerosis-ms-107620 https://curecurrent.com/trials/cranberry-for-prevention-of-urinary-tract-infections-in-multiple-sclerosis-patients-107621 https://curecurrent.com/trials/safety-and-efficacy-study-of-copaxone-administered-in-combination-with-n-acetylcysteine-107622 https://curecurrent.com/trials/cognitive-testing-for-the-pain-quality-assessment-scale-pqas-107623 https://curecurrent.com/trials/psychometric-validation-of-cognitive-endpoints-107624 https://curecurrent.com/trials/a-safety-and-efficacy-study-of-cnto1275-in-patients-with-multiple-sclerosis-107625 https://curecurrent.com/trials/qolbet-quality-of-life-in-patients-with-early-relapsing-remitting-multiple-sclerosis-treated-with-betaferon-in-korea-107626 https://curecurrent.com/trials/efficacy-and-safety-of-fingolimod-in-patients-with-relapsing-remitting-multiple-sclerosis-107627 https://curecurrent.com/trials/study-of-sb-683699-compared-to-placebo-in-subjects-with-relapsing-remitting-multiple-sclerosis-ms-107628 https://curecurrent.com/trials/cognitive-effects-of-immunomodulatory-drugs-in-ms-107629 https://curecurrent.com/trials/sensori-motor-integration-training-in-multiple-sclerosis-107630 https://curecurrent.com/trials/efficacy-of-cyclophosphamide-versus-methylprednisolone-in-patients-with-secondary-progressive-multiple-sclerosis-107631 https://curecurrent.com/trials/rivastigmine-in-multiple-sclerosis-patients-with-cognitive-impairment-107632 https://curecurrent.com/trials/study-to-evaluate-treating-chronic-cerebrospinal-venous-insufficiency-ccsvi-in-multiple-sclerosis-patients-107633 https://curecurrent.com/trials/herbal-therapy-for-subcutaneous-injection-site-reactions-in-multiple-sclerosis-107634 https://curecurrent.com/trials/a-prospective-study-of-spasticity-in-individuals-with-multiple-sclerosis-107635 https://curecurrent.com/trials/benefit-extension-study-107636 https://curecurrent.com/trials/open-label-extension-study-to-evaluate-the-safety-tolerability-and-activity-of-oral-fampridine-sr-in-patients-with-multi-107637 https://curecurrent.com/trials/pharmacokinetic-immunological-and-biochemical-sample-collection-and-analysis-of-a-tysabri-patient-cohort-107638 https://curecurrent.com/trials/open-label-extension-study-to-evaluate-the-safety-tolerability-and-activity-of-oral-fampridine-sr-in-patients-with-multi-107639 https://curecurrent.com/trials/topical-rapamycin-therapy-to-alleviate-cutaneous-manifestations-of-tuberous-sclerosis-complex-tsc-and-neurofibromatosis-107640 https://curecurrent.com/trials/open-label-extension-study-to-evaluate-the-safety-tolerability-and-activity-of-oral-fampridine-sr-tablets-in-multiple-sc-107641 https://curecurrent.com/trials/natalizumab-treatment-of-progressive-multiple-sclerosis-107642 https://curecurrent.com/trials/efficacy-and-safety-of-the-pain-relieving-effect-of-dronabinol-in-central-neuropathic-pain-related-to-multiple-sclerosis-107643 https://curecurrent.com/trials/compliance-with-avonex-ps-in-patients-with-relapsing-remitting-ms-107644 https://curecurrent.com/trials/american-ginseng-treatment-for-multiple-sclerosis-related-fatigue-107645 https://curecurrent.com/trials/longitudinal-pharmacokinetic-pharmacodynamic-immunological-and-biochemical-107646 https://curecurrent.com/trials/telephone-interview-of-patients-that-participated-in-the-the-pivotal-betaferon-ms-trial-107647 https://curecurrent.com/trials/popart-mus-prevention-of-post-partum-relapses-with-progestin-and-estradiol-in-multiple-sclerosis-107648 https://curecurrent.com/trials/duloxetine-for-multiple-sclerosis-pain-107649 https://curecurrent.com/trials/trichuris-suis-ova-therapy-for-relapsing-multiple-sclerosis-a-safety-study-107650 https://curecurrent.com/trials/mesenchymal-stem-cells-in-multiple-sclerosis-mscims-107651 https://curecurrent.com/trials/the-effects-of-aerobics-training-on-balance-in-patients-with-multiple-sclerosis-107652 https://curecurrent.com/trials/clinical-trial-comparing-treatment-of-relapsing-remitting-multiple-sclerosis-rr-ms-with-two-doses-of-glatiramer-acetate-107653 https://curecurrent.com/trials/t-cell-vaccination-in-patients-with-progressive-multiple-sclerosis-107654 https://curecurrent.com/trials/cytotron-delivered-rotational-field-quantum-nuclear-magnetic-resonance-therapy-for-multiple-sclerosis-107655 https://curecurrent.com/trials/colecalciferol-as-an-add-on-treatment-to-subcutaneously-administered-interferon-beta-1b-for-treatment-of-multiple-sclero-107656 https://curecurrent.com/trials/cdp323-biomarker-study-107657 https://curecurrent.com/trials/placebo-controlled-study-in-subjects-with-relapsing-forms-of-ms-to-evaluate-the-safety-tolerability-and-effects-of-cdp32-107658 https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-atorvastatin-40-mg-in-patients-with-relapsing-remitting-multiple-sclerosis-treated-w-107659 https://curecurrent.com/trials/effect-of-tysabri-in-patients-with-relapsing-remitting-multiple-sclerosis-a-follow-up-magnetization-transfer-imaging-mti-107660 https://curecurrent.com/trials/can-vitamin-d-supplementation-prevent-bone-loss-in-persons-with-multiple-sclerosis-107661 https://curecurrent.com/trials/aimspro-in-the-treatment-of-bladder-dysfunction-in-secondary-progressive-multiple-sclerosis-107662 https://curecurrent.com/trials/impact-of-vitamin-a-on-multiple-sclerosis-ms-107663 https://curecurrent.com/trials/study-of-alternative-exercise-therapies-for-progressive-multiple-sclerosis-ms-107664 https://curecurrent.com/trials/health-behavior-change-in-chronic-disease-management-107665 https://curecurrent.com/trials/the-effects-of-erythropoietin-on-clinical-disability-and-brain-pathology-in-patients-with-progressive-multiple-sclerosis-107666 https://curecurrent.com/trials/zenapax-to-treat-multiple-sclerosis-107667 https://curecurrent.com/trials/safety-and-efficacy-study-of-oral-fampridine-sr-in-patients-with-multiple-sclerosis-107668 https://curecurrent.com/trials/safety-effectiveness-of-adding-monthly-dexamethasone-to-weekly-avonex-for-ms-107669 https://curecurrent.com/trials/alfuzosin-for-voiding-dysfunction-in-multiple-sclerosis-ms-107670 https://curecurrent.com/trials/cohort-study-of-clinically-isolated-syndrome-and-early-multiple-sclerosis-107671 https://curecurrent.com/trials/oral-corticotherapy-in-megadoses-to-treat-multiple-sclerosis-during-relapse-107672 https://curecurrent.com/trials/colecalciferol-as-an-add-on-treatment-to-interferon-beta-1b-for-treatment-of-multiple-sclerosis-ms-107673 https://curecurrent.com/trials/efficacy-of-anti-tubercular-vaccination-in-multiple-sclerosis-107674 https://curecurrent.com/trials/ambulation-study-in-multiple-sclerosis-107675 https://curecurrent.com/trials/evaluating-alemtuzumab-as-a-treatment-in-stabilizing-neurocognitive-function-in-relapsing-remitting-multiple-sclerosis-p-107676 https://curecurrent.com/trials/efficacy-and-safety-of-fty720-in-patients-with-relapsing-multiple-sclerosis-ms-107677 https://curecurrent.com/trials/supported-treadmill-training-for-progressive-multiple-sclerosis-107678 https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-effectiveness-of-novantrone-therapy-followed-by-copaxone-for-multiple-sclerosis-107679 https://curecurrent.com/trials/a-study-to-evaluate-readiness-to-self-inject-on-adherence-and-compliance-to-copaxone-therapy-107680 https://curecurrent.com/trials/safety-and-efficacy-study-of-copaxone-administered-in-combination-with-minocycline-107681 https://curecurrent.com/trials/a-study-comparing-shared-solutions-plus-ms-center-support-versus-shared-solutions-alone-107682 https://curecurrent.com/trials/a-study-to-evaluate-the-impact-on-skin-injection-site-reactions-of-taking-an-antihistamine-zyrtec-or-placebo-prior-to-da-107683 https://curecurrent.com/trials/the-effectiveness-of-locomotor-therapy-using-robot-driven-gait-orthosis-system-in-multiple-sclerosis-patients-107684 https://curecurrent.com/trials/a-study-to-evaluate-the-effectiveness-tolerability-and-safety-of-laquinimod-107685 https://curecurrent.com/trials/a-study-to-evaluate-the-impact-on-skin-injection-site-reactions-of-using-alcohol-wipes-prior-to-daily-injections-of-copa-107686 https://curecurrent.com/trials/success-of-titration-analgesics-and-b-e-t-a-nurse-support-on-acceptance-rates-in-early-multiple-sclerosis-ms-treatment-w-107687 https://curecurrent.com/trials/biomarkers-and-response-to-natalizumab-for-multiple-sclerosis-treatment-107688 https://curecurrent.com/trials/12-week-safety-evaluation-of-oral-cs-0777-in-multiple-sclerosis-patients-107689 https://curecurrent.com/trials/efficacy-of-3-4-dap-in-fatigue-associated-with-multiple-sclerosis-107690 https://curecurrent.com/trials/simvastatin-treatment-of-patients-with-acute-optic-neuritis-107691 https://curecurrent.com/trials/a-study-to-evaluate-the-preliminary-efficacy-pharmacokinetics-and-immunogenicity-of-bms-188667-administered-to-subjects-107692 https://curecurrent.com/trials/study-comparing-corpus-callosum-atrophy-as-a-marker-of-later-development-of-cognitive-impairment-in-patients-with-multip-107693 https://curecurrent.com/trials/neurocognitive-changes-in-patients-with-remitting-relapsing-multiple-sclerosis-treated-with-natalizumab-107694 https://curecurrent.com/trials/randomized-study-designed-to-look-at-disease-progression-using-2-currently-fda-approved-drugs-for-the-treatment-of-rrms-107695 https://curecurrent.com/trials/simvastatin-as-an-add-on-treatment-to-interferon-beta-1a-for-the-treatment-of-relapsing-remitting-multiple-sclerosis-107696 https://curecurrent.com/trials/visual-impairment-oscillopsia-and-multiple-sclerosis-107697 https://curecurrent.com/trials/study-of-the-safety-and-efficacy-of-mln1202-in-patients-in-multiple-sclerosis-107698 https://curecurrent.com/trials/a-study-for-patients-with-relapsing-remitting-multiple-sclerosis-107699 https://curecurrent.com/trials/a-study-for-patients-with-multiple-sclerosis-107700 https://curecurrent.com/trials/vitamin-d3-supplementation-and-the-t-cell-compartment-in-multiple-sclerosis-ms-107701 https://curecurrent.com/trials/simvastatin-in-relapsing-remitting-multiple-sclerosis-rrms-patients-using-avonex-compared-to-placebo-107702 https://curecurrent.com/trials/efficacy-and-safety-study-of-gb-0998-for-treatment-of-systemic-sclerosis-107703 https://curecurrent.com/trials/novel-immune-markers-in-patients-with-multiple-sclerosis-107704 https://curecurrent.com/trials/real-world-betaseron-health-economic-outcomes-study-for-relapsing-forms-of-multiple-sclerosis-107705 https://curecurrent.com/trials/open-lable-extension-study-on-safety-and-efficacy-of-neramexane-to-treat-congenital-and-acquired-nystagmus-107706 https://curecurrent.com/trials/evaluation-of-neural-loss-in-multiple-sclerosis-and-neuromyelitis-optica-using-high-resolution-oct-107707 https://curecurrent.com/trials/validation-of-an-obstacle-course-used-in-patients-with-muscle-tightness-107708 https://curecurrent.com/trials/nasal-administration-of-dexamethasone-for-multiple-sclerosis-ms-treatment-107709 https://curecurrent.com/trials/a-study-for-patients-with-secondary-progressive-multiple-sclerosis-107710 https://curecurrent.com/trials/a-study-to-evaluate-the-long-term-safety-and-effectiveness-of-novantrone-therapy-followed-by-copaxone-treatment-for-mult-107711 https://curecurrent.com/trials/intravesical-injection-of-botulinum-toxin-a-versus-saline-for-neurogenic-detrusor-overactivity-107712 https://curecurrent.com/trials/avonex-15-year-long-term-follow-up-study-107713 https://curecurrent.com/trials/atp-expression-in-lymphocytes-of-ms-patients-by-means-of-immuknow-assay-107714 https://curecurrent.com/trials/optical-coherence-tomography-glatiramer-in-clinically-isolated-syndrome-or-early-relapsing-remitting-multiple-sclerosis-107715 https://curecurrent.com/trials/a-randomised-controlled-trial-of-neuroprotection-with-lamotrigine-in-secondary-progressive-multiple-sclerosis-107716 https://curecurrent.com/trials/climate-influence-on-physiotherapy-in-multiple-sclerosis-107717 https://curecurrent.com/trials/study-to-determine-if-avonex-and-rebif-work-comparably-well-in-subjects-with-relapsing-multiple-sclerosis-107718 https://curecurrent.com/trials/a-study-to-test-the-effectiveness-and-safety-of-a-new-higher-40mg-dose-of-copaxone-compared-to-copaxone-20mg-the-current-107719 https://curecurrent.com/trials/levetiracetam-in-central-pain-in-multiple-sclerosis-ms-107720 https://curecurrent.com/trials/focus-fatigue-outcome-in-copaxone-users-107721 https://curecurrent.com/trials/exploratory-study-to-investigate-the-reparative-and-regenerative-potential-of-alemtuzumab-in-relapsing-remitting-multipl-107722 https://curecurrent.com/trials/beyond-pilot-study-107723 https://curecurrent.com/trials/characteristic-study-on-chinese-patients-with-multiple-sclerosis-107724 https://curecurrent.com/trials/a-multicenter-study-to-assess-the-effect-of-plasma-exchange-in-accelerating-the-clearance-of-natalizumab-in-subjects-wit-107725 https://curecurrent.com/trials/efficacy-and-safety-of-mbp8298-in-subjects-with-secondary-progressive-multiple-sclerosis-107726 https://curecurrent.com/trials/phase-ii-high-dose-cyclophosphamide-for-multiple-sclerosis-107727 https://curecurrent.com/trials/atorvastatin-40-mg-in-patients-with-relapsing-remitting-multiple-sclerosis-treated-with-interferon-beta-1b-107728 https://curecurrent.com/trials/early-ifnb-1a-and-atorvastatin-combination-therapy-of-isolated-clinical-syndrome-suggestive-of-multiple-sclerosis-107729 https://curecurrent.com/trials/open-label-natalizumab-safety-extension-study-107730 https://curecurrent.com/trials/safety-and-efficacy-of-natalizumab-in-combination-with-avonex-in-the-treatment-of-multiple-sclerosis-107731 https://curecurrent.com/trials/natalizumab-in-combination-with-glatiramer-acetate-ga-in-patients-with-relapsing-remitting-multiple-sclerosis-107732 https://curecurrent.com/trials/ger-009-06-avx-early-therapy-in-multiple-sclerosis-107733 https://curecurrent.com/trials/development-and-evaluation-of-a-new-palliative-care-service-for-people-severely-affected-with-multiple-sclerosis-ms-107734 https://curecurrent.com/trials/immunogenicity-and-safety-study-of-serum-free-avonex-107735 https://curecurrent.com/trials/the-neuroprotective-effect-of-lamotrigine-and-interferon-beta-1a-in-patients-with-relapsing-remitting-multiple-sclerosis-107736 https://curecurrent.com/trials/open-label-safety-extension-study-of-avonex-107737 https://curecurrent.com/trials/patient-satisfaction-study-of-single-use-autoinjector-for-the-delivery-of-pre-filled-avonex-syringe-107738 https://curecurrent.com/trials/comparison-of-campath-and-rebif-treatment-on-cognition-in-multiple-sclerosis-ms-107739 https://curecurrent.com/trials/pharmacodynamic-study-to-better-understand-the-therapeutic-response-and-immunomodulatory-effects-of-avonex-in-multiple-s-107740 https://curecurrent.com/trials/a-bioequivalence-study-of-serum-free-avonex-and-serum-containing-avonex-in-healthy-volunteers-107741 https://curecurrent.com/trials/motor-imagery-practice-in-neurological-rehabilitation-107742 https://curecurrent.com/trials/motor-point-stimulation-for-conditioning-the-diaphragm-of-patients-with-amyotrophic-lateral-sclerosis-als-107743 https://curecurrent.com/trials/diagnostic-study-of-quantitative-imaging-and-spectroscopy-in-patients-with-multiple-sclerosis-107744 https://curecurrent.com/trials/differential-immune-effects-of-natalizumab-107745 https://curecurrent.com/trials/safety-study-of-rtl1000-recombinant-t-cell-receptor-ligand-in-subjects-with-multiple-sclerosis-107746 https://curecurrent.com/trials/one-year-extension-study-to-protocol-c2-5-tz-ms-05-107747 https://curecurrent.com/trials/study-of-nighttime-dosing-of-sublingual-tizanidine-12-mg-in-multiple-sclerosis-ms-patients-with-significant-spasticity-107748 https://curecurrent.com/trials/far-infrared-irradiation-for-managing-and-treating-multiple-sclerosis-ms-107749 https://curecurrent.com/trials/eszopiclone-for-improving-sleep-in-multiple-sclerosis-ms-107750 https://curecurrent.com/trials/beyond-betaferon-betaseron-efficacy-yielding-outcomes-of-a-new-dose-in-multiple-sclerosis-ms-patients-107751 https://curecurrent.com/trials/tolerability-and-bioavailability-of-the-p144-peptide-inhibitor-of-tgf-1-after-topical-administration-in-healthy-voluntee-107752 https://curecurrent.com/trials/safety-and-preliminary-effectiveness-of-av650-in-patients-with-spasticity-associated-with-multiple-sclerosis-107753 https://curecurrent.com/trials/whole-body-vibration-therapy-in-a-participant-with-multiple-sclerosis-related-balance-deficits-a-case-study-107754 https://curecurrent.com/trials/phase-iii-randomized-double-blind-placebo-controlled-study-of-intravenous-immune-globulin-for-multiple-sclerosis-107755 https://curecurrent.com/trials/how-side-effects-of-avonex-are-affected-by-gradually-increasing-to-full-dose-vs-starting-at-full-dose-107756 https://curecurrent.com/trials/multiple-sclerosis-and-heavy-progressive-resistance-training-107757 https://curecurrent.com/trials/study-of-subcutaneous-daclizumab-in-patients-with-active-relapsing-forms-of-multiple-sclerosis-107758 https://curecurrent.com/trials/constraint-induced-ci-movement-therapy-for-progressive-multiple-sclerosis-ms-107759 https://curecurrent.com/trials/auditory-function-in-patients-with-and-without-multiple-sclerosis-107760 https://curecurrent.com/trials/a-study-of-c105-on-cognitive-dysfunction-in-persons-with-multiple-sclerosis-107761 https://curecurrent.com/trials/a-randomized-placebo-controlled-crossover-design-study-of-the-effects-of-low-dose-naltrexone-107762 https://curecurrent.com/trials/avonex-combination-trial-act-107763 https://curecurrent.com/trials/trial-of-efficacy-and-safety-of-sirolimus-in-tuberous-sclerosis-and-lam-107764 https://curecurrent.com/trials/immunotherapy-with-bht-3009-alone-or-combined-with-atorvastatin-in-patients-with-multiple-sclerosis-107765 https://curecurrent.com/trials/safety-trial-of-high-dose-oral-vitamin-d3-with-calcium-in-multiple-sclerosis-107766 https://curecurrent.com/trials/evaluation-of-an-altered-peptide-ligand-nbi-5788-in-patients-with-relapsing-multiple-sclerosis-ms-107767 https://curecurrent.com/trials/early-ifnb-1a-and-simvastatin-combination-therapy-in-clinically-isolated-syndrome-suggestive-of-multiple-sclerosis-107768 https://curecurrent.com/trials/a-48-week-24-week-baseline-followed-by-a-24-week-treatment-phase-ii-pilot-study-of-the-tolerability-and-effect-efficacy-107769 https://curecurrent.com/trials/safety-tolerability-and-effectiveness-of-cgp77116-in-patients-with-multiple-sclerosis-ms-107770 https://curecurrent.com/trials/the-effect-of-sildenafil-citrate-viagra-registered-trademark-on-brain-blood-flow-in-multiple-sclerosis-patients-107771 https://curecurrent.com/trials/rolipram-to-treat-multiple-sclerosis-107772 https://curecurrent.com/trials/mr-perfusion-imaging-and-hypercapnia-increased-carbon-dioxide-to-study-new-blood-vessel-formation-in-multiple-sclerosis-107773 https://curecurrent.com/trials/evaluation-of-the-efficacy-of-cesamet-for-the-treatment-of-pain-in-patients-with-multiple-sclerosis-107774 https://curecurrent.com/trials/bht-3009-immunotherapy-in-relapsing-remitting-multiple-sclerosis-107775 https://curecurrent.com/trials/safety-of-avonex-treatment-in-multiple-sclerosis-patients-with-neutralizing-antibodies-to-interferon-beta-therapy-107776 https://curecurrent.com/trials/investigating-if-interferon-beta-can-be-used-in-patients-with-ms-after-they-have-developed-neutralizing-antibodies-107777 https://curecurrent.com/trials/study-evaluating-mitoxantrone-in-multiple-sclerosis-107778 https://curecurrent.com/trials/a-serologic-study-to-correlate-beta-ifn-nab-titers-to-beta-ifn-induced-biomarker-response-in-patients-with-multiple-scle-107779 https://curecurrent.com/trials/fatigue-in-multiple-sclerosis-evaluated-with-3-mri-and-transcranial-magnetic-stimulation-107780 https://curecurrent.com/trials/does-quality-of-life-improve-in-multiple-sclerosis-patients-treated-with-interferon-beta-1a-107781 https://curecurrent.com/trials/an-fmri-study-of-treatment-optimization-comparing-two-disease-modifying-therapies-used-to-treat-relapsing-remitting-mult-107782 https://curecurrent.com/trials/a-fmri-functional-magnetic-resonance-imaging-research-study-to-learn-more-about-multiple-sclerosis-and-individuals-poten-107783 https://curecurrent.com/trials/correlation-between-cognitive-functions-and-mri-in-multiple-sclerosis-107784 https://curecurrent.com/trials/promoting-physical-activity-for-persons-with-multiple-sclerosis-107785 https://curecurrent.com/trials/optimizing-ifn-beta-1b-dose-107786 https://curecurrent.com/trials/rapamycin-therapy-for-patients-with-tuberous-sclerosis-complex-and-sporadic-lam-107787 https://curecurrent.com/trials/cannabis-for-spasticity-in-multiple-sclerosis-107788 https://curecurrent.com/trials/factors-that-influence-compliance-with-disease-modifying-therapy-in-multiple-sclerosis-107789 https://curecurrent.com/trials/t-cell-vaccination-in-multiple-sclerosis-ms-107790 https://curecurrent.com/trials/evaluation-of-efficiency-of-ritalin-in-multiple-sclerosis-ms-patients-107791 https://curecurrent.com/trials/effects-of-spinal-cord-injury-on-female-sexual-response-107792 https://curecurrent.com/trials/the-efficacy-and-safety-of-escitalopram-for-depression-in-multiple-sclerosis-107793 https://curecurrent.com/trials/combination-therapy-provigil-avonex-to-treat-cognitive-problems-in-ms-107794 https://curecurrent.com/trials/tcv-01-002-t-cell-vaccination-in-the-treatment-of-probable-multiple-sclerosis-107795 https://curecurrent.com/trials/yoga-effect-on-attention-in-aging-multiple-sclerosis-107796 https://curecurrent.com/trials/natural-antioxidants-in-the-treatment-of-multiple-sclerosis-107797 https://curecurrent.com/trials/omega-3-fatty-acid-treatment-in-multiple-sclerosis-107798 https://curecurrent.com/trials/gait-evaluation-in-multiple-sclerosis-patients-treated-with-glatiramer-acetate-107799 https://curecurrent.com/trials/short-term-effects-of-medicinal-cannabis-therapy-on-spasticity-in-multiple-sclerosis-107800 https://curecurrent.com/trials/measuring-the-balance-improvement-on-multiple-sclerosis-patients-after-a-short-training-period-with-an-apos-all-phase-of-107801 https://curecurrent.com/trials/optic-neuritis-treatment-trial-ontt-107802 https://curecurrent.com/trials/longitudinal-optic-neuritis-study-lons-107803 https://curecurrent.com/trials/treatment-of-multiple-sclerosis-using-over-the-counter-inosine-107804 https://curecurrent.com/trials/combination-therapy-of-betaseron-prograf-in-multiple-sclerosis-107805 https://curecurrent.com/trials/fatigue-treatment-using-provigil-107806 https://curecurrent.com/trials/infections-and-autoimmunity-autobodies-screening-in-multiple-sclerosis-107807 https://curecurrent.com/trials/multimodal-mri-in-multiple-sclerosis-ms-reliability-and-follow-up-107808 https://curecurrent.com/trials/sleep-disorders-in-patients-with-multiple-sclerosis-107809 https://curecurrent.com/trials/evaluation-of-a-new-therapeutic-strategy-in-early-and-active-relapsing-remitting-multiple-sclerosis-107810 https://curecurrent.com/trials/a-safety-study-of-combination-treatment-with-avonex-and-zocor-in-relapsing-remitting-multiple-sclerosis-107811 https://curecurrent.com/trials/use-of-cannabinoids-in-patients-with-multiple-sclerosis-107812 https://curecurrent.com/trials/a-safety-study-of-combination-treatment-with-avonex-and-placebo-controlled-dosing-of-topamax-in-relapsing-remitting-mult-107813 https://curecurrent.com/trials/safety-and-tolerability-of-interferon-beta-1a-and-estroprogestins-association-in-ms-patients-107814 https://curecurrent.com/trials/phase-iii-randomized-double-blind-sham-controlled-study-of-plasma-exchange-for-acute-severe-attacks-of-inflammatory-demy-107815 https://curecurrent.com/trials/phase-i-pilot-study-of-total-body-irradiation-anti-thymocyte-globulin-and-cyclophosphamide-followed-by-syngeneic-or-auto-107816 https://curecurrent.com/trials/phase-i-study-of-high-dose-cyclophosphamide-and-total-body-irradiation-with-t-lymphocyte-depleted-autologous-peripheral-107817 https://curecurrent.com/trials/antibiotic-treatment-trial-directed-against-chlamydia-pneumonia-in-multiple-sclerosis-107818 https://curecurrent.com/trials/a-maintenance-extension-of-phase-i-pilot-study-of-chimeric-anti-cd4-antibody-m-t412-in-patients-with-multiple-sclerosis-107819 https://curecurrent.com/trials/phase-iii-randomized-double-blind-placebo-controlled-study-of-copolymer-1-for-relapsing-remitting-multiple-sclerosis-107820 https://curecurrent.com/trials/study-of-creatine-monohydrate-in-patients-with-amyotrophic-lateral-sclerosis-107821 https://curecurrent.com/trials/efficacy-and-safety-study-of-qaw039-in-patients-with-severe-asthma-inadequately-controlled-with-standard-of-care-asthma-107822 https://curecurrent.com/trials/testing-the-effects-of-temperature-humidity-on-children-with-and-without-asthma-in-an-environmental-climatic-chamber-107823 https://curecurrent.com/trials/long-term-effect-of-dupilumab-in-n-erd-107824 https://curecurrent.com/trials/co-morbidity-and-refractory-asthma-uk-severe-asthma-registry-107825 https://curecurrent.com/trials/a-long-term-study-of-kt-621-administered-orally-to-participants-with-asthma-previously-enrolled-in-a-kt-621-asthma-study-107826 https://curecurrent.com/trials/a-study-to-investigate-gb-0895-adjunctive-therapy-in-adults-and-adolescents-with-severe-uncontrolled-asthma-solairia-2-107827 https://curecurrent.com/trials/a-study-to-investigate-gb-0895-adjunctive-therapy-in-adults-and-adolescents-with-severe-uncontrolled-asthma-solairia-1-107828 https://curecurrent.com/trials/clinical-and-demographic-features-of-patients-with-uncontrolled-severe-asthma-in-russia-corsar-107829 https://curecurrent.com/trials/a-study-to-learn-about-the-study-medicine-called-tilrekimig-in-people-with-severe-asthma-107830 https://curecurrent.com/trials/effect-of-video-game-based-breathing-exercises-on-respiratory-dysfunction-in-acos-107831 https://curecurrent.com/trials/pragmatic-open-label-randomized-clinical-trial-of-ff-umec-vi-vs-non-ellipta-usual-care-ics-laba-for-adult-participants-w-107832 https://curecurrent.com/trials/smart-home-feasibility-trial-107833 https://curecurrent.com/trials/a-study-of-kt-621-administered-orally-to-adult-participants-with-moderate-to-severe-eosinophilic-asthma-107834 https://curecurrent.com/trials/a-study-to-investigate-the-efficacy-and-safety-of-tezepelumab-compared-with-placebo-in-children-5-to-12-years-old-with-s-107835 https://curecurrent.com/trials/a-randomized-double-blind-placebo-controlled-trial-on-efficacy-and-safety-of-fluticasone-propionate-albuterol-sulfate-co-107836 https://curecurrent.com/trials/open-label-study-to-assess-reduction-of-background-asthma-medication-while-sustaining-asthma-control-and-clinical-remiss-107837 https://curecurrent.com/trials/study-of-hospitalised-patients-with-acute-respiratory-conditions-107838 https://curecurrent.com/trials/a-study-to-assess-and-compare-safety-and-tolerability-of-3-months-treatment-with-salbutamol-administered-via-mdi-contain-107839 https://curecurrent.com/trials/a-research-study-of-house-dust-mite-hdm-slit-tablet-for-the-treatment-of-hdm-allergy-in-chinese-participants-aged-12-65-107840 https://curecurrent.com/trials/safety-and-efficacy-comparison-between-chf5993-100-6-12-5-g-pmdi-to-seretide-evohaler-125-25-g-pmdi-in-adolescent-subjec-107841 https://curecurrent.com/trials/acoustic-waveform-respiratory-evaluation-107842 https://curecurrent.com/trials/prevent-wheeze-trial-107843 https://curecurrent.com/trials/a-study-to-learn-about-the-study-medicine-called-pf-07275315-in-people-with-moderate-to-severe-asthma-107844 https://curecurrent.com/trials/longitudinal-observational-study-of-severe-asthma-107845 https://curecurrent.com/trials/long-term-safety-and-efficacy-evaluation-of-subcutaneous-amlitelimab-in-adult-participants-with-moderate-to-severe-asthm-107846 https://curecurrent.com/trials/educational-needs-of-patients-with-severe-asthma-on-targeted-immunotherapies-107847 https://curecurrent.com/trials/coincide-cardineurovascular-disease-and-obstructive-airway-disease-107848 https://curecurrent.com/trials/a-study-assessing-the-effect-of-dupilumab-on-inducing-clinical-remission-in-asthma-107849 https://curecurrent.com/trials/tgf-beta-and-susceptibility-to-rsv-107850 https://curecurrent.com/trials/asthma-ctrl-smart-trial-107851 https://curecurrent.com/trials/evaluation-of-safety-side-effects-and-how-the-drug-inhaled-chf10136-is-absorbed-modified-and-removed-from-the-body-in-he-107852 https://curecurrent.com/trials/modeling-bronchial-epithelium-in-severe-asthma-with-human-induced-pluripotent-stem-cells-ipsc-107853 https://curecurrent.com/trials/asthma-crisis-in-paediatrics-impact-of-a-care-pathway-in-primary-and-hospital-care-107854 https://curecurrent.com/trials/safety-and-feasibility-study-of-intranasal-mesenchymal-trophic-factor-mtf-for-treatment-of-asthma-107855 https://curecurrent.com/trials/study-of-inhaled-aro-rage-in-allergen-induced-mild-asthma-107856 https://curecurrent.com/trials/the-allergen-reduction-and-child-health-study-archs-107857 https://curecurrent.com/trials/5htp-regulation-of-asthma-in-children-107858 https://curecurrent.com/trials/a-study-to-test-if-a-fixed-dose-combination-of-fluticasone-propionate-albuterol-sulfate-is-effective-in-preventing-asthm-107859 https://curecurrent.com/trials/scaling-up-the-integrated-care-pathway-for-acute-asthma-to-all-osakidetza-pediatric-services-through-a-cluster-randomize-107860 https://curecurrent.com/trials/lung-resident-memory-th2-cells-in-asthma-107861 https://curecurrent.com/trials/a-study-to-investigate-the-efficacy-and-safety-of-gsk5784283-compared-with-placebo-in-participants-with-uncontrolled-ast-107862 https://curecurrent.com/trials/a-study-to-compare-safety-of-4-weeks-exposure-to-propellants-hydrofluoroalkane-1-1-difluoroethane-hfa-152a-and-hfa-1-1-1-107863 https://curecurrent.com/trials/a-study-to-compare-the-efficacy-safety-and-tolerability-of-ff-umec-vi-with-ff-vi-in-12-17-year-olds-with-asthma-107864 https://curecurrent.com/trials/a-multicentre-randomised-double-blind-parallel-group-placebo-controlled-time-to-first-asthma-exacerbation-phase-iii-effi-107865 https://curecurrent.com/trials/tezspire-tezepelumab-asthma-japan-post-marketing-study-pms-107866 https://curecurrent.com/trials/thoracic-spine-rotation-stretching-and-scapular-retraction-in-asthma-patients-107867 https://curecurrent.com/trials/activation-and-function-of-eosinophils-in-conditions-with-blood-or-tissue-eosinophilia-107868 https://curecurrent.com/trials/induced-tolerogenic-dendritic-cells-as-modulators-of-allergic-asthma-107869 https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-qvm149-indacaterol-acetate-glycopyrronium-bromide-mometasone-furoate-vers-107870 https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-qmf149-indacaterol-acetate-mometasone-furoate-versus-budesonide-in-childr-107871 https://curecurrent.com/trials/a-study-of-jnj-95597528-in-participants-with-inadequately-controlled-moderate-to-severe-asthma-107872 https://curecurrent.com/trials/a-study-to-investigate-the-efficacy-and-safety-of-gsk5784283-compared-with-placebo-in-participants-with-uncontrolled-ast-107873 https://curecurrent.com/trials/benralizumab-airway-remodeling-study-in-severe-eosinophilic-asthmatics-107874 https://curecurrent.com/trials/sustained-asthma-remission-and-reduced-relapse-using-a-comprehensive-management-strategy-sarre-coms-107875 https://curecurrent.com/trials/study-to-compare-the-effects-of-z7200-and-symbicort-turbohaler-on-respiratory-imaging-parameters-in-asthmatic-patients-107876 https://curecurrent.com/trials/dose-range-finding-study-to-assess-efficacy-and-safety-of-tozorakimab-in-adults-with-uncontrolled-asthma-on-medium-to-hi-107877 https://curecurrent.com/trials/evaluation-of-the-asthma-management-program-to-promote-activity-for-students-in-schools-asthma-pass-107878 https://curecurrent.com/trials/a-study-evaluating-disease-characteristics-and-outcomes-in-participants-with-asthma-in-routine-clinical-practice-107879 https://curecurrent.com/trials/canadian-consortium-on-airway-mucus-occlusions-in-asthma-copd-and-chronic-cough-107880 https://curecurrent.com/trials/real-world-effectiveness-of-depemokimab-in-allergic-bronchopulmonary-aspergillosis-with-severe-eosinophilic-asthma-107881 https://curecurrent.com/trials/impact-of-gdmt-in-uncontrolled-asthma-patients-receiving-mhd-inhaled-corticosteroids-long-acting-2-agonist-107882 https://curecurrent.com/trials/microglia-activation-in-asthma-107883 https://curecurrent.com/trials/novel-method-for-removal-of-orally-deposited-inhaled-fluticasone-propionate-107884 https://curecurrent.com/trials/post-exacerbation-asthma-clinic-telecare-intervention-to-reduce-recurrent-exacerbations-107885 https://curecurrent.com/trials/env-294-for-moderate-to-severe-asthma-a-12-week-study-in-adults-107886 https://curecurrent.com/trials/a-24-week-prospective-open-label-multicenter-single-arm-rpms-study-in-real-world-setting-for-atectura-107887 https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-pk-and-immunogenicity-of-apg777-in-adults-with-asthma-107888 https://curecurrent.com/trials/breztri-regulatory-post-marketing-surveillance-in-korea-107889 https://curecurrent.com/trials/early-diagnosis-and-treatment-of-undiagnosed-asthma-or-copd-the-ucap-2-trial-107890 https://curecurrent.com/trials/study-of-formoterol-6-mcg-fluticasone-125-mcg-by-eurofarma-laborat-rios-s-a-versus-alenia-6-mcg-200-mcg-in-patients-with-107891 https://curecurrent.com/trials/evolve-study-the-real-life-clinical-practice-with-tezepelumab-in-greece-107892 https://curecurrent.com/trials/a-multicenter-randomized-parallel-two-period-non-inferiority-study-of-eurofarmavsalenia-in-asthma-and-copd-treatment-107893 https://curecurrent.com/trials/n-watch-nottingham-wheeze-assessment-in-tidal-children-107894 https://curecurrent.com/trials/a-study-to-evaluate-brenipatide-compared-with-placebo-in-adult-participants-with-uncontrolled-moderate-to-severe-asthma-107895 https://curecurrent.com/trials/roll-over-study-for-participants-who-have-completed-a-previous-clinical-study-with-benralizumab-fasenra-and-benefit-from-107896 https://curecurrent.com/trials/study-of-lunsekimig-sar443765-compared-with-placebo-in-adults-with-high-risk-asthma-107897 https://curecurrent.com/trials/camp-air-efficacy-and-cost-effectiveness-in-urban-adolescents-107898 https://curecurrent.com/trials/long-term-safety-and-efficacy-evaluation-of-lunsekimig-sar443765-in-adult-participants-with-asthma-107899 https://curecurrent.com/trials/assess-accuracy-of-primary-care-asthma-and-copd-diagnosis-using-oscillometry-and-feno-vs-specialist-diagnosis-107900 https://curecurrent.com/trials/detection-of-cav1-calcium-channels-in-inflammatory-cells-of-asthmatic-children-107901 https://curecurrent.com/trials/resources-and-education-for-addressing-chronic-health-reach-107902 https://curecurrent.com/trials/effect-of-cpap-treatment-in-patients-with-severe-uncontrolled-asthma-the-asthma-sleep-trial-107903 https://curecurrent.com/trials/a-study-to-investigate-efficacy-and-safety-of-pt027-compared-with-pt007-in-symptomatic-chinese-adults-with-asthma-107904 https://curecurrent.com/trials/primary-care-asthma-feno-trial-107905 https://curecurrent.com/trials/a-real-life-observational-study-in-severe-eosinophilic-asthma-adult-participant-treated-with-benralizumab-in-italy-107906 https://curecurrent.com/trials/smart-implementation-effectiveness-trial-2-107907 https://curecurrent.com/trials/smart-implementation-effectiveness-trial-1-107908 https://curecurrent.com/trials/bioequivalence-study-of-aju-r713-and-r713r-in-healthy-adult-volunteers-107909 https://curecurrent.com/trials/genes-soy-isoflavones-and-virus-107910 https://curecurrent.com/trials/structured-nursing-intervention-for-adults-with-poorly-controlled-asthma-a-pilot-study-107911 https://curecurrent.com/trials/quartz-comparative-effectiveness-of-switching-from-albuterol-to-albuterol-budesonide-versus-adding-low-dose-ics-or-ltra-107912 https://curecurrent.com/trials/a-comparison-of-diagnostic-testing-modalities-in-the-assessment-of-asthma-107913 https://curecurrent.com/trials/randomised-control-trial-to-understand-whether-prescribing-choice-for-inhalers-is-influenced-by-knowledge-of-the-carbon-107914 https://curecurrent.com/trials/characterization-and-clinical-outcomes-of-severe-asthma-patients-in-israel-treated-with-benralizumab-sail-b-107915 https://curecurrent.com/trials/artificially-intelligent-robot-control-107916 https://curecurrent.com/trials/t2air-real-world-efficacy-and-safety-of-biologics-targeting-type-2-inflammation-in-asthma-and-copd-107917 https://curecurrent.com/trials/rademikibart-add-on-treatment-of-an-acute-asthma-exacerbation-seabreeze-stat-asthma-107918 https://curecurrent.com/trials/pulmonary-stimulation-for-asthma-relief-107919 https://curecurrent.com/trials/real-world-evaluation-of-tezepelumab-for-chronic-rhinosinusitis-with-nasal-polyps-in-russia-107920 https://curecurrent.com/trials/fasenra-an-asthma-study-107921 https://curecurrent.com/trials/post-vent-the-sequelae-personalized-prognostic-modeling-for-consequences-of-neonatal-intermittent-hypoxemia-in-preterm-i-107922 https://curecurrent.com/trials/digital-delivery-of-person-centered-transitional-care-107923 https://curecurrent.com/trials/reducing-asthma-attacks-in-disadvantaged-school-children-with-asthma-107924 https://curecurrent.com/trials/boosting-referrals-to-asthma-specialists-for-patients-seen-at-the-emergency-room-for-an-asthma-exacerbation-107925 https://curecurrent.com/trials/explore-the-diagnostic-value-of-bronchodilation-test-with-portable-oscillometry-in-asthma-diagnosis-107926 https://curecurrent.com/trials/study-of-aro-muc5ac-in-healthy-subjects-and-patients-with-muco-obstructive-lung-disease-107927 https://curecurrent.com/trials/a-randomised-feasibility-study-of-cpap-in-large-airway-collapse-107928 https://curecurrent.com/trials/forced-oscillations-technique-during-a-metacholine-test-in-children-107929 https://curecurrent.com/trials/childhood-allergy-and-the-neonatal-environment-107930 https://curecurrent.com/trials/development-and-validation-of-the-indian-asthma-care-bundle-for-reducing-readmission-and-improving-post-hospitalisation-107931 https://curecurrent.com/trials/childhood-infection-and-immunity-longitudinal-cohort-107932 https://curecurrent.com/trials/diagnosing-asthma-with-clinically-accessible-non-invasive-and-efficient-tests-a-child-inclusive-translational-investigat-107933 https://curecurrent.com/trials/comparison-between-chf5993-pmdi-200-6-12-5-g-hfa-152a-vs-chf5993-pmdi-200-6-12-5-g-hfa-134a-in-subjects-with-asthma-trec-107934 https://curecurrent.com/trials/effects-of-beclometasone-dipropionate-formoterol-fumarate-via-next-haler-in-a-real-world-study-on-asthma-control-107935 https://curecurrent.com/trials/a-randomized-phase-ib-double-blind-placebo-controlled-study-to-evaluate-the-safety-and-efficacy-of-skb575-hbm7575-in-par-107936 https://curecurrent.com/trials/phase-ii-trial-of-rc1416-injection-in-asthma-107937 https://curecurrent.com/trials/fasenra-pediatric-japan-post-marketing-study-pms-107938 https://curecurrent.com/trials/chest-a-collaboration-with-community-health-centers-to-implement-smart-for-asthma-107939 https://curecurrent.com/trials/assessment-of-small-airways-involvement-in-asthma-atlantis-107940 https://curecurrent.com/trials/rig-101-trial-in-healthy-adults-and-adults-with-asthma-107941 https://curecurrent.com/trials/asthmaxcel-voice-study-107942 https://curecurrent.com/trials/observational-study-on-therapy-pathways-of-asthamics-treated-with-ics-laba-lama-therapy-in-a-real-world-setting-107943 https://curecurrent.com/trials/sample-collections-from-the-airways-of-asthmatic-patients-107944 https://curecurrent.com/trials/a-study-to-investigate-the-effect-on-lung-function-of-bda-formulated-with-a-next-generation-propellant-compared-with-an-107945 https://curecurrent.com/trials/efficacy-and-safety-of-cp006-inhalation-powder-in-participants-with-asthma-107946 https://curecurrent.com/trials/a-study-to-evaluate-the-treatment-pattern-of-moderate-to-severe-asthma-patients-in-china-107947 https://curecurrent.com/trials/bioequivalence-study-of-budesonide-formoterol-inhalation-powder-in-healthy-participants-107948 https://curecurrent.com/trials/impact-of-sleep-duration-on-immune-balance-in-urban-children-with-asthma-107949 https://curecurrent.com/trials/the-puerto-rico-asthma-integrated-response-program-pr-air-107950 https://curecurrent.com/trials/inhaler-lung-deposition-in-chronic-obstructive-pulmonary-disease-copd-107951 https://curecurrent.com/trials/step-phase-iiib-study-of-benralizumab-to-step-down-maintenance-therapy-in-patients-with-severe-eosinophilic-asthma-107952 https://curecurrent.com/trials/using-a-digital-spacer-for-inhaler-technique-education-in-pediatric-asthma-107953 https://curecurrent.com/trials/phase-3b-study-in-patients-with-severe-asthma-treated-with-tezepelumab-107954 https://curecurrent.com/trials/evaluate-pharmacokinetics-and-safety-of-slow-release-dhea-107955 https://curecurrent.com/trials/a-study-to-learn-how-different-amounts-of-the-study-medicine-called-pf-08103402-are-tolerated-and-act-in-the-body-in-hea-107956 https://curecurrent.com/trials/phase-1-study-evaluating-safety-and-pharmacokinetics-of-asy202-in-adults-with-asthma-107957 https://curecurrent.com/trials/the-cox-2-gene-and-the-immune-system-107958 https://curecurrent.com/trials/nhales-natural-history-of-asthma-with-longitudinal-environmental-sampling-107959 https://curecurrent.com/trials/new-approaches-for-empowering-studies-of-asthma-in-populations-of-african-descent-107960 https://curecurrent.com/trials/efficacy-of-high-dose-continuous-intravenous-magnesium-sulfate-infusion-vs-standard-intravenous-magnesium-sulfate-therap-107961 https://curecurrent.com/trials/smart-inhaler-and-remote-asthma-management-in-adolescents-with-intellectual-and-developmental-disabilities-107962 https://curecurrent.com/trials/combination-of-high-flow-nasal-oxygen-optiflow-and-vibrating-membrane-nebuliser-aerogen-in-the-pre-hospital-setting-befo-107963 https://curecurrent.com/trials/ginger-s-therapeutic-potential-in-asthma-107964 https://curecurrent.com/trials/asthma-lung-sounds-with-wearable-stethoscope-107965 https://curecurrent.com/trials/real-world-study-assessing-efficacy-of-tezepelumab-in-patients-with-severe-asthma-regardless-of-phenotype-in-russia-107966 https://curecurrent.com/trials/a-non-interventional-prospective-study-with-benralizumab-107967 https://curecurrent.com/trials/a-phase-1-trial-of-amg-691-in-healthy-chinese-and-japanese-volunteers-107968 https://curecurrent.com/trials/budesonide-formoterol-inhalation-powder-in-adults-with-asthma-107969 https://curecurrent.com/trials/a-study-evaluating-the-effect-of-inhaled-pt007-as-mdi-versus-placebo-mdi-and-ventolin-evohaler-on-lung-function-in-adult-107970 https://curecurrent.com/trials/rademikibart-iv-for-acute-asthma-and-copd-exacerbation-107971 https://curecurrent.com/trials/a-phase-ii-study-to-investigate-lung-function-with-2-different-doses-of-inhaled-glycopyrronium-taken-with-bff-compared-t-107972 https://curecurrent.com/trials/a-study-of-depemokimab-in-participants-of-6-to-11-years-of-age-107973 https://curecurrent.com/trials/expression-of-tslp-isoforms-in-asthma-107974 https://curecurrent.com/trials/this-study-aims-to-compare-asthma-control-in-children-monitored-with-feno-against-a-historical-cohort-without-feno-secon-107975 https://curecurrent.com/trials/self-management-of-asthma-by-forced-oscillation-technique-107976 https://curecurrent.com/trials/withania-somnifera-for-moderate-to-severe-persistent-asthma-107977 https://curecurrent.com/trials/a-study-to-assess-the-potential-for-airway-sensitivity-reactions-with-propellants-hfa-152a-test-and-hfa-134a-reference-a-107978 https://curecurrent.com/trials/tezepelumab-pro-study-107979 https://curecurrent.com/trials/registry-of-asthma-characterization-and-recruitment-3-racr3-107980 https://curecurrent.com/trials/creation-of-a-biological-collection-of-bronchiai-and-pulmonary-tissues-from-surgical-waste-107981 https://curecurrent.com/trials/early-high-flow-oxygen-therapy-with-nebulized-beta-2-agonist-using-a-vibrating-mesh-for-the-management-of-moderate-to-se-107982 https://curecurrent.com/trials/to-identify-persons-who-are-susceptible-to-wsp-induced-inflammation-and-examine-the-role-of-gstm1-and-other-factors-in-t-107983 https://curecurrent.com/trials/symptom-driven-ics-laba-therapy-for-adolescent-patients-with-asthma-non-adherent-to-daily-maintenance-inhalers-107984 https://curecurrent.com/trials/washington-university-severe-asthma-research-program-iii-107985 https://curecurrent.com/trials/efficacy-of-l-menthol-on-breathlessness-in-asthma-107986 https://curecurrent.com/trials/symptom-driven-ics-laba-therapy-for-patients-with-asthma-non-adherent-to-daily-maintenance-inhalers-107987 https://curecurrent.com/trials/tqc2731-clinical-trial-for-the-treatment-of-severe-asthma-with-injection-107988 https://curecurrent.com/trials/pharmacokinetics-pharmacodynamics-safety-and-tolerability-of-glycopyrronium-bromide-in-children-6-to-less-than-12-years-107989 https://curecurrent.com/trials/respiratory-admittance-by-oscillometry-in-children-107990 https://curecurrent.com/trials/real-world-and-genomic-data-based-asthma-insight-through-network-analysis-107991 https://curecurrent.com/trials/a-translational-study-to-describe-clinical-characteristics-biomarkers-and-to-identify-phenotypes-and-endotypes-associate-107992 https://curecurrent.com/trials/bilevel-positive-airway-pressure-bpap-for-severe-asthma-107993 https://curecurrent.com/trials/changes-in-eosinophil-cationic-protein-and-sputum-eosinophils-following-allergen-immunotherapy-107994 https://curecurrent.com/trials/asthma-exacerbations-respiratory-management-international-survey-107995 https://curecurrent.com/trials/physical-activity-promotion-and-clinical-remission-in-severe-asthma-107996 https://curecurrent.com/trials/a-study-of-efficacy-and-safety-of-depemokimab-compared-with-placebo-in-adults-and-adolescents-with-at-risk-type-2-asthma-107997 https://curecurrent.com/trials/beclometasone-dipropionate-and-formoterol-inhalation-aerosol-for-asthma-107998 https://curecurrent.com/trials/characterization-of-adult-subjects-for-asthmatic-research-studies-107999 https://curecurrent.com/trials/clinical-and-autonomic-efficacy-of-digital-gamified-diaphragmatic-training-in-pediatric-pulmonary-rehabilitation-108000 https://curecurrent.com/trials/predictive-factors-for-a-positive-exercise-bronchial-hyperresponsiveness-test-108001 https://curecurrent.com/trials/evaluating-the-efficacy-and-safety-of-pt027-compared-with-pt007-administered-as-needed-in-participants-12-to-18-years-of-108002 https://curecurrent.com/trials/fcv-vs-vcv-in-obstructive-and-asthmatic-patients-108003 https://curecurrent.com/trials/efficacy-and-safety-of-subcutaneous-dupilumab-in-participants-with-asthma-asthmatic-wheeze-aged-2-to-6-years-liberty-ast-108004 https://curecurrent.com/trials/effects-of-wet-cupping-therapy-in-patients-with-asthma-108005 https://curecurrent.com/trials/investigating-the-impact-of-early-time-restricted-eating-on-health-outcomes-and-quality-of-life-in-adults-with-mild-cont-108006 https://curecurrent.com/trials/the-effects-of-positive-airway-pressure-on-the-mucolytic-effects-of-nac-team-108007 https://curecurrent.com/trials/the-barts-charity-children-s-environmental-health-clinic-108008 https://curecurrent.com/trials/mechanisms-of-benefit-of-il4ra-inhibition-in-aspirin-exacerbated-respiratory-disease-108009 https://curecurrent.com/trials/effect-of-ai-artificial-intelligence-based-storytelling-video-on-anxiety-and-fear-during-skin-prick-test-in-children-108010 https://curecurrent.com/trials/an-observational-prospective-multicenter-study-to-evaluate-the-biologic-use-and-outcomes-in-chinese-asthma-patients-108011 https://curecurrent.com/trials/pediatric-asthma-trial-of-corticosteroid-heterogeneity-patch-trial-of-dexamethasone-versus-methylprednisolone-for-pediat-108012 https://curecurrent.com/trials/sensory-mechanical-responses-to-eucapneic-voluntary-hyperventilation-and-mannitol-108013 https://curecurrent.com/trials/a-dose-finding-study-with-an-anti-tslp-antibody-gsk5784283-in-adults-aged-18-to-75-years-of-age-with-uncontrolled-asthma-108014 https://curecurrent.com/trials/dupilumab-effects-against-aeroallergen-challenge-108015 https://curecurrent.com/trials/real-world-effectiveness-of-tezepelumab-in-allergic-bronchopulmonary-aspergillosis-108016 https://curecurrent.com/trials/primary-care-implementation-and-evaluation-of-coach-mclungs-108017 https://curecurrent.com/trials/a-phase-2-dose-ranging-study-assessing-rocatinlimab-in-moderate-to-severe-asthma-108018 https://curecurrent.com/trials/a-community-based-swimming-and-inspiratory-muscle-training-intervention-to-promote-physical-activity-and-asthma-control-108019 https://curecurrent.com/trials/azithromycin-for-critical-asthma-pediatrics-108020 https://curecurrent.com/trials/a-study-to-evaluate-solriktug-in-adult-participants-with-asthma-108021 https://curecurrent.com/trials/a-randomized-double-blind-placebo-controlled-multi-centre-study-to-assess-the-efficacy-of-purethal-mites-mixture-50-000-108022 https://curecurrent.com/trials/foster-100-6-mg-nexthaler-versus-foster-100-6mg-pressurized-metered-dose-inhaler-pmdi-in-patients-with-controlled-asthma-108023 https://curecurrent.com/trials/a-multi-centered-randomized-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-shr-1703-in-eos-108024 https://curecurrent.com/trials/implementation-of-asthma-community-home-and-school-management-program-asthma-champs-108025 https://curecurrent.com/trials/virtual-breathing-intervention-for-enhancing-asthma-related-quality-of-life-a-randomized-controlled-trial-108026 https://curecurrent.com/trials/coping-with-asthma-throughout-life-management-program-108027 https://curecurrent.com/trials/lungvitamin-d-and-omega-3-trial-lungvital-108028 https://curecurrent.com/trials/eams-eco-implementation-of-a-tool-for-climate-conscious-inhaler-prescribing-108029 https://curecurrent.com/trials/app-based-medical-device-for-education-and-training-of-inhalation-technique-108030 https://curecurrent.com/trials/measuring-the-effect-of-dupilumab-treatment-on-mucociliary-clearance-mcc-in-subjects-with-moderate-to-severe-asthma-108031 https://curecurrent.com/trials/study-of-pra-216-in-healthy-participants-and-participants-with-mild-to-moderate-asthma-108032 https://curecurrent.com/trials/su-jok-therapy-to-improve-dyspnea-and-insomnia-in-asthma-108033 https://curecurrent.com/trials/reduce-identified-uncontrolled-asthma-108034 https://curecurrent.com/trials/comparison-of-microglial-activation-in-severe-asthma-and-healthy-controls-108035 https://curecurrent.com/trials/pharmacokinetic-profile-and-safety-of-fluticasone-propionate-and-albuterol-sulfate-in-combination-when-compared-to-fluti-108036 https://curecurrent.com/trials/implementation-of-a-joint-pulmonologist-and-ent-consultation-in-the-care-pathway-of-patients-suffering-from-asthma-and-c-108037 https://curecurrent.com/trials/self-management-in-adults-with-asthma-or-copd-108038 https://curecurrent.com/trials/structure-and-function-mri-of-asthma-108039 https://curecurrent.com/trials/a-24-week-rpms-study-in-real-world-setting-for-enerzair-108040 https://curecurrent.com/trials/reverse-lung-airway-and-vascular-remodeling-in-asthma-remission-renorm-108041 https://curecurrent.com/trials/betri-prospective-asthma-control-in-single-inhaler-ics-laba-lama-87-5-9-pmdi-bdp-ff-gb-100-6-12-5-g-vs-single-inhaler-ic-108042 https://curecurrent.com/trials/paxt-pulmonary-imaging-of-mild-asthma-using-129xe-mri-and-tc-99-labeled-carbon-imaging-tc99cimaging-108043 https://curecurrent.com/trials/biomarkers-and-respiratory-omics-as-new-children-opportunities-study-of-clinical-outcomes-and-predictivity-evaluation-108044 https://curecurrent.com/trials/automated-inhaler-monitoring-for-asthma-medication-usage-108045 https://curecurrent.com/trials/vitamin-d-status-and-asthma-control-pulmonary-function-and-oxidative-stress-in-adults-with-bronchial-asthma-108046 https://curecurrent.com/trials/a-comparative-study-to-investigate-the-difference-in-blood-levels-of-two-different-formulations-of-gsk5784283-108047 https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-efficacy-and-safety-of-frevecitinib-kn-002-in-patients-with-severe-asthma-108048 https://curecurrent.com/trials/iv-dexamethasone-vs-methylprednisolone-in-children-with-severe-asthma-exacerbation-108049 https://curecurrent.com/trials/nlr-elr-and-sii-index-as-biomarkers-of-asthma-control-108050 https://curecurrent.com/trials/a-pharmacist-led-intervention-to-increase-inhaler-access-and-reduce-hospital-readmissions-pillar-108051 https://curecurrent.com/trials/nebulized-ketamine-for-severe-asthma-attacks-in-children-108052 https://curecurrent.com/trials/effect-of-pilates-training-versus-high-intensity-interval-training-on-cardiorespiratory-fitness-in-asthmatic-patients-108053 https://curecurrent.com/trials/giving-asthmatics-intramuscular-steroids-for-preventing-return-to-the-emergency-department-108054 https://curecurrent.com/trials/development-of-a-novel-non-invasive-inflammometry-following-allergen-challenge-in-patients-with-mild-allergic-asthma-108055 https://curecurrent.com/trials/multi-omics-in-severe-asthma-from-olive-pollen-allergy-108056 https://curecurrent.com/trials/wearable-electronic-breath-sound-sensing-device-108057 https://curecurrent.com/trials/a-study-of-remote-asthma-management-using-an-integrated-artificial-intelligence-assisted-ehr-dashboard-and-mobile-device-108058 https://curecurrent.com/trials/this-is-a-non-interventional-study-to-assess-demographic-characteristics-and-patient-reported-outcomes-in-china-patients-108059 https://curecurrent.com/trials/a-phase-1-study-of-cizutamig-in-ige-mediated-diseases-108060 https://curecurrent.com/trials/a-study-of-bbt002-in-healthy-volunteers-hvs-and-in-patients-with-chronic-rhinosinusitis-with-nasal-polyps-crswnp-with-or-108061 https://curecurrent.com/trials/developing-a-childhood-asthma-risk-passive-digital-marker-108062 https://curecurrent.com/trials/tapering-of-inhaled-corticosteroids-in-tezepelumab-treated-asthma-patients-impact-on-clinical-outcomes-108063 https://curecurrent.com/trials/vr-vs-treadmill-exercise-in-children-with-asthma-108064 https://curecurrent.com/trials/comparison-of-box-breathing-and-rhythmic-breathing-techniques-in-patients-with-asthma-108065 https://curecurrent.com/trials/observational-study-on-the-clinical-profile-of-patients-with-uncontrolled-severe-asthma-treated-with-tezepelumab-in-ital-108066 https://curecurrent.com/trials/comparative-real-world-effectiveness-of-sq-sublingual-immunotherapy-slit-tablets-vs-controls-in-allergic-rhinitis-and-as-108067 https://curecurrent.com/trials/a-study-testing-the-superiority-of-chf-1535-pmdi-800-24-g-total-daily-dose-compared-with-chf-718-pmdi-800-g-total-daily-108068 https://curecurrent.com/trials/innovative-steroid-treatment-to-reduce-asthma-development-in-children-after-first-time-rhinovirus-induced-wheezing-108069 https://curecurrent.com/trials/description-of-characteristics-such-as-age-previous-and-concurrent-treatments-associated-diseases-of-patients-with-asthm-108070 https://curecurrent.com/trials/effect-of-linvemastat-in-patients-with-partially-controlled-asthma-symmponia-108071 https://curecurrent.com/trials/a-study-of-lebrikizumab-in-participants-with-uncontrolled-asthma-who-are-on-inhaled-corticosteroids-and-a-second-control-108072 https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-safety-of-lebrikizumab-in-adult-patients-with-mild-to-moderate-asthma-108073 https://curecurrent.com/trials/a-biorepository-of-multiple-allergic-diseases-madrep-with-longitudinal-follow-up-108074 https://curecurrent.com/trials/tezepelumab-in-the-treatment-of-emergency-room-asthma-in-adults-teraa-108075 https://curecurrent.com/trials/combination-short-acting-bronchodilator-and-inhaled-corticosteroid-rescue-therapy-on-health-outcomes-in-routine-care-108076 https://curecurrent.com/trials/effectiveness-and-safety-study-of-tezepelumab-in-adults-adolescent-participants-with-severe-asthma-in-the-united-states-108077 https://curecurrent.com/trials/anakinra-rescue-treatment-for-moderate-asthma-attacks-artma-108078 https://curecurrent.com/trials/a-study-to-investigate-how-budesonide-and-formoterol-move-through-the-body-pharmacokinetics-when-delivered-with-differen-108079 https://curecurrent.com/trials/impact-of-metabolic-dysfunction-and-mucus-plugging-on-asthma-physiology-108080 https://curecurrent.com/trials/administration-of-ars-1-or-albuterol-in-subjects-with-persistent-asthma-108081 https://curecurrent.com/trials/effect-of-chromium-weight-reduction-on-adult-asthma-control-108082 https://curecurrent.com/trials/a-study-comparing-a-pre-filled-safety-syringe-and-an-autoinjector-for-shr-1703-injection-in-healthy-participants-108083 https://curecurrent.com/trials/prospective-multicentre-study-on-symptoms-in-first-onset-bronchial-asthma-in-children-and-adolescents-108084 https://curecurrent.com/trials/severe-asthma-mepolizumab-and-affect-samba-study-108085 https://curecurrent.com/trials/y-of-central-maryland-head-start-asthma-implementation-108086 https://curecurrent.com/trials/reversing-airway-remodelling-with-tezepelumab-108087 https://curecurrent.com/trials/asthma-symptom-perception-study-108088 https://curecurrent.com/trials/evaluate-the-efficacy-and-safety-of-fb704a-in-adult-with-severe-asthma-108089 https://curecurrent.com/trials/efficacy-and-safety-of-chf-5993-100-6-12-5-g-hfa-152a-pmdi-in-patients-with-asthma-uncontrolled-on-medium-doses-of-inhal-108090 https://curecurrent.com/trials/the-extended-salford-lung-study-ex-sls-data-access-project-108091 https://curecurrent.com/trials/quantitative-chest-ct-and-multi-omics-to-distinguish-asthma-from-copd-and-predict-treatment-response-108092 https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-study-of-povorcitinib-in-participants-with-inadequately-controlled-moderate-108093 https://curecurrent.com/trials/airway-redox-and-gender-determinants-in-severe-asthma-108094 https://curecurrent.com/trials/a-trial-evaluating-novel-technologies-for-the-diagnosis-of-asthma-the-lung-tech-trial-108095 https://curecurrent.com/trials/sub-sensitivity-to-long-acting-bronchodilators-laba-108096 https://curecurrent.com/trials/implementation-of-evidence-based-breathing-retraining-for-patients-with-asthma-in-region-zealand-108097 https://curecurrent.com/trials/study-to-assess-pt010-in-adult-and-adolescent-participants-with-inadequately-controlled-asthma-logos-108098 https://curecurrent.com/trials/a-study-of-cdx-622-in-participants-with-mild-to-moderate-asthma-108099 https://curecurrent.com/trials/depemokimab-asthma-imaging-and-bronchoscopy-sub-study-108100 https://curecurrent.com/trials/treating-exacerbations-of-asthma-with-oral-montelukast-in-children-108101 https://curecurrent.com/trials/addressing-quality-of-life-clinical-outcomes-and-mechanisms-in-uncontrolled-asthma-following-the-dash-dietary-pattern-108102 https://curecurrent.com/trials/a-histamine-pharmacodynamic-biomarker-to-guide-treatment-in-pediatric-asthma-has3-108103 https://curecurrent.com/trials/protocol-cause-03-cheetah-108104 https://curecurrent.com/trials/the-impact-of-anxiety-depression-on-the-efficacy-of-asthma-control-drugs-and-the-construction-of-a-predictive-model-for-108105 https://curecurrent.com/trials/evaluation-of-ventilation-defects-downstream-of-mucus-plugs-in-patients-with-muco-obstructive-lung-disease-108106 https://curecurrent.com/trials/study-to-assess-pt010-in-adult-and-adolescent-participants-with-inadequately-controlled-asthma-kalos-108107 https://curecurrent.com/trials/quantifying-the-burden-of-type-2-t2-inflammation-in-asthma-108108 https://curecurrent.com/trials/a-study-of-lebrikizumab-in-adolescent-participants-with-uncontrolled-asthma-who-are-on-inhaled-corticosteroids-and-a-sec-108109 https://curecurrent.com/trials/the-inflammatory-profile-of-exacerbations-in-patients-with-severe-asthma-receiving-tezepelumab-the-tezex-study-108110 https://curecurrent.com/trials/evaluation-of-allergen-specific-vaccination-of-dog-allergic-patients-in-swedish-practice-108111 https://curecurrent.com/trials/examining-changes-in-nasal-il-1-during-acute-asthma-exacerbation-in-adolescents-108112 https://curecurrent.com/trials/effect-of-spacer-use-on-exacerbation-risk-in-high-risk-older-adults-with-chronic-airway-diseases-receiving-triple-therap-108113 https://curecurrent.com/trials/medication-adherence-with-telehealthcare-medication-therapy-management-108114 https://curecurrent.com/trials/phase-iia-trial-in-participants-with-asthma-to-evaluate-impact-of-intranasal-eth47-on-development-of-asthma-related-symp-108115 https://curecurrent.com/trials/triple-in-asthma-high-strength-versus-ics-laba-hs-and-tiotropium-trigger-108116 https://curecurrent.com/trials/triple-in-asthma-with-uncontrolled-patient-on-medium-strength-of-ics-laba-108117 https://curecurrent.com/trials/near-fatal-asthma-in-children-and-young-people-108118 https://curecurrent.com/trials/dose-ranging-study-of-lq036-single-domain-antibody-nebulization-solution-in-poorly-controlled-asthma-108119 https://curecurrent.com/trials/plant-stanol-esters-and-preventing-asthma-symptoms-108120 https://curecurrent.com/trials/therapeutic-equivalence-of-chf5993-pmdi-100-6-12-5-g-hfa-152a-in-subjects-with-mild-to-moderate-asthma-108121 https://curecurrent.com/trials/project-asthma-aligning-with-schools-to-help-manage-asthma-and-improve-outcomes-108122 https://curecurrent.com/trials/aligning-with-schools-to-help-manage-asthma-project-asthma-108123 https://curecurrent.com/trials/the-effect-of-buteyko-breathing-technique-on-asthma-control-and-quality-of-life-in-children-with-asthma-108124 https://curecurrent.com/trials/a-study-to-compare-the-relative-potency-of-salbutamol-administered-via-metered-dose-inhalers-mdi-containing-propellants-108125 https://curecurrent.com/trials/the-effect-of-asthma-flare-up-clinic-after-exacerbation-108126 https://curecurrent.com/trials/azithromycin-therapy-in-preschoolers-with-a-severe-wheezing-episode-diagnosed-at-the-emergency-department-108127 https://curecurrent.com/trials/t2-biomarkers-predictive-value-in-occupational-asthma-after-cessation-of-exposure-108128 https://curecurrent.com/trials/air-support-artificially-intelligent-robot-air-support-for-pediatric-asthma-education-108129 https://curecurrent.com/trials/remote-anxiety-management-for-ics-resistant-asthma-study-108130 https://curecurrent.com/trials/tezepelumab-efficacy-and-safety-in-reducing-oral-corticosteroid-use-in-adults-with-oral-corticosteroid-dependent-asthma-108131 https://curecurrent.com/trials/thermotherapy-against-persistent-bacterial-lung-infections-108132 https://curecurrent.com/trials/troms-birch-rust-allergy-study-allergy-to-birch-rust-a-possible-explanation-to-seasonal-airway-allergy-during-autumn-108133 https://curecurrent.com/trials/a-phase-1-randomized-double-blind-placebo-controlled-study-evaluating-amg-691-in-healthy-participants-and-participants-w-108134 https://curecurrent.com/trials/execise-intervention-in-adult-severe-asthma-108135 https://curecurrent.com/trials/infant-rsv-immunity-study-108136 https://curecurrent.com/trials/a-study-to-compare-the-pharmacokinetics-pk-of-depemokimab-when-delivered-with-a-safety-syringe-device-ssd-or-an-autoinje-108137 https://curecurrent.com/trials/ct-air-trapping-for-the-early-identification-of-benralizumab-responders-among-eosinophilic-asthma-patients-108138 https://curecurrent.com/trials/breathlessness-perceptions-within-respiratory-diseases-108139 https://curecurrent.com/trials/children-s-health-respiratory-inflammation-and-short-term-air-pollution-108140 https://curecurrent.com/trials/trial-of-jyb1904-in-patients-with-allergic-asthma-108141 https://curecurrent.com/trials/granite-airsupra-effectiveness-in-the-real-world-108142 https://curecurrent.com/trials/standard-patient-training-versus-vik-chatbot-guided-training-a-randomized-controlled-trial-for-asthma-patients-108143 https://curecurrent.com/trials/a-coping-skills-program-for-children-with-asthma-108144 https://curecurrent.com/trials/active-airways-for-children-and-young-people-with-asthma-108145 https://curecurrent.com/trials/the-effect-of-nac-on-lung-function-and-ct-mucus-score-108146 https://curecurrent.com/trials/efficacy-and-safety-of-roflumilast-in-japanese-patients-with-bronchial-asthma-20-to-70-y-apta-2217-05-108147 https://curecurrent.com/trials/long-term-study-of-safety-and-efficacy-of-roflumilast-in-japanese-patients-with-bronchial-asthma-20-to-71-y-apta-2217-07-108148 https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-tolerability-of-multiple-dose-of-ibi3002-in-healthy-and-asthmatic-participants-108149 https://curecurrent.com/trials/is-asthma-in-subjects-with-obstructive-sleep-apnoea-osa-due-to-dysanapsis-108150 https://curecurrent.com/trials/breathing-exercises-in-asthma-targeting-dysfunctional-breathing-108151 https://curecurrent.com/trials/use-of-dupilumab-in-asthma-in-real-world-setting-108152 https://curecurrent.com/trials/assessment-of-bronchial-thickness-using-mri-in-asthma-108153 https://curecurrent.com/trials/evaluation-of-time-sensitive-nebulization-mode-converter-108154 https://curecurrent.com/trials/poly-unsaturated-fats-for-improving-nasal-polyps-and-asthma-108155 https://curecurrent.com/trials/reference-equations-and-normative-data-for-isometric-quadriceps-and-handgrip-muscles-strength-in-southern-european-popul-108156 https://curecurrent.com/trials/evaluation-of-clinical-effect-of-acupuncture-on-acute-exacerbation-of-bronchial-asthma-108157 https://curecurrent.com/trials/a-study-to-evaluate-the-diagnostic-performance-of-portable-oscillometry-across-chronic-respiratory-diseases-108158 https://curecurrent.com/trials/inhaler-trainer-efficacy-study-108159 https://curecurrent.com/trials/a-trial-of-shr-1905-in-subjects-with-severe-uncontrolled-asthma-108160 https://curecurrent.com/trials/fish-oil-supplementation-during-pregnancy-for-prevention-of-asthma-eczema-and-allergies-in-childhood-108161 https://curecurrent.com/trials/a-study-in-male-and-female-adolescent-participants-with-severe-uncontrolled-asthma-starting-treatment-with-dupilumab-inj-108162 https://curecurrent.com/trials/registry-of-asthma-patients-initiating-dupixent-108163 https://curecurrent.com/trials/physical-activity-intervention-for-black-women-with-asthma-108164 https://curecurrent.com/trials/tezepelumab-tezspire-regulatory-postmarketing-surveillance-in-korea-108165 https://curecurrent.com/trials/study-of-inflammatory-and-physiological-profiles-of-healthy-and-diseased-lung-108166 https://curecurrent.com/trials/impact-of-multi-component-intervention-on-suspected-asthma-population-108167 https://curecurrent.com/trials/humidity-asthma-interventions-for-low-socioeconomic-status-children-108168 https://curecurrent.com/trials/cost-effective-air-filtration-intervention-in-low-income-housing-to-reduce-asthma-morbidity-108169 https://curecurrent.com/trials/use-of-fenotrack-device-for-monitoring-changes-of-fractional-exhaled-nitric-oxide-feno-in-uncontrolled-asthma-subjects-a-108170 https://curecurrent.com/trials/a-study-of-itolizumab-eq001-to-evaluate-the-safety-tolerability-pk-pd-and-clinical-activity-in-uncontrolled-asthma-108171 https://curecurrent.com/trials/chronic-effects-of-photobiomodulation-with-an-led-vest-on-functional-capacity-inflammatory-markers-and-muscle-perfusion-108172 https://curecurrent.com/trials/n95-masks-for-lung-health-while-golfing-during-wildfire-season-108173 https://curecurrent.com/trials/oral-bacterial-extract-for-the-prevention-of-wheezing-lower-respiratory-tract-illness-108174 https://curecurrent.com/trials/retrospective-analysis-of-systemic-glucocorticoid-mediated-long-term-effects-patient-pathways-and-economic-burden-across-108175 https://curecurrent.com/trials/a-study-of-acupuncture-for-treating-asthma-108176 https://curecurrent.com/trials/effect-of-acute-hypoxia-on-right-ventricular-function-in-asthma-108177 https://curecurrent.com/trials/multimodal-assisted-diagnosis-for-pediatric-respiratory-diseases-using-questionnaires-cough-sounds-and-breath-sounds-108178 https://curecurrent.com/trials/bronchial-thermoplasty-for-severe-asthma-with-dynamic-hyperinflation-108179 https://curecurrent.com/trials/a-study-of-humab-ox40l-in-the-prevention-of-allergen-induced-airway-obstruction-in-adults-with-mild-allergic-asthma-108180 https://curecurrent.com/trials/asthma-inflammation-research-108181 https://curecurrent.com/trials/effects-of-abdominal-binder-on-dysnea-control-pause-and-quality-of-life-in-asthmatic-patients-108182 https://curecurrent.com/trials/the-development-of-the-walsh-asthma-self-management-programme-and-feasibility-of-implementation-in-adults-with-asthma-in-108183 https://curecurrent.com/trials/asthma-and-technology-in-emerging-african-american-adults-108184 https://curecurrent.com/trials/obstructive-sleep-apnoea-and-difficult-asthma-osada-108185 https://curecurrent.com/trials/study-of-gsk3511294-in-healthy-chinese-participants-108186 https://curecurrent.com/trials/asthma-navigator-intervention-to-improve-health-equity-in-children-108187 https://curecurrent.com/trials/efficacy-of-dupilumab-added-to-medium-dose-inhaled-corticosteroid-long-acting-beta-agonist-ics-laba-in-comparison-to-ics-108188 https://curecurrent.com/trials/blood-exosomal-multi-omics-and-lung-radiomics-for-predicting-efficacy-and-prognosis-of-severe-eosinophilic-acos-with-bio-108189 https://curecurrent.com/trials/replacing-gas-stoves-with-portable-electric-appliances-to-improve-indoor-air-quality-and-asthma-control-108190 https://curecurrent.com/trials/pulmonary-rehabilitation-in-african-countries-108191 https://curecurrent.com/trials/transplacental-transmission-of-rsv-ttrsv-108192 https://curecurrent.com/trials/gsnor-phenotyping-gsno-challenge-in-severe-asthma-108193 https://curecurrent.com/trials/home-telemonitoring-of-resting-spontaneous-breathing-in-severe-asthma-a-pilot-study-108194 https://curecurrent.com/trials/predicting-dynamic-inspiratory-muscle-strength-in-copd-and-asthma-patients-108195 https://curecurrent.com/trials/bacterial-lysate-in-preventing-asthma-108196 https://curecurrent.com/trials/taiwan-severe-asthma-biologic-registry-108197 https://curecurrent.com/trials/a-study-of-gsk3511294-depemokimab-compared-with-mepolizumab-or-benralizumab-in-participants-with-severe-asthma-with-an-e-108198 https://curecurrent.com/trials/measures-for-bioaerosol-reduction-in-the-salmon-industry-108199 https://curecurrent.com/trials/a-long-term-safety-and-efficacy-study-of-verekitug-upb-101-in-adult-participants-with-severe-asthma-valour-108200 https://curecurrent.com/trials/consequences-of-covid-19-pandemic-on-childhood-asthma-108201 https://curecurrent.com/trials/eosinophils-endotypes-in-chronic-airway-inflammatory-diseases-108202 https://curecurrent.com/trials/online-cognitive-behavior-therapy-for-anxiety-related-to-pediatric-asthma-108203 https://curecurrent.com/trials/telemedicine-enhanced-asthma-management-uniting-providers-for-teens-team-up-for-teens-108204 https://curecurrent.com/trials/randomised-clinical-trial-to-investigate-efficacy-and-safety-of-benralizumab-30-mg-sc-as-an-add-on-therapy-in-uncontroll-108205 https://curecurrent.com/trials/study-to-evaluate-the-therapeutic-equivalence-and-safety-of-fluticasone-furoate-and-vilanterol-inhalation-powder-100-mcg-108206 https://curecurrent.com/trials/randomized-trial-maternal-vitamin-d-supplementation-to-prevent-childhood-asthma-vdaart-108207 https://curecurrent.com/trials/inspiratory-muscle-training-on-the-severity-of-exercise-induced-bronchoconstriction-and-time-trial-performance-imt-eib-108208 https://curecurrent.com/trials/implementing-a-guidelines-based-m-health-intervention-for-high-risk-asthma-patients-108209 https://curecurrent.com/trials/turkish-validation-and-reliability-study-of-the-brompton-breathing-pattern-assessment-tool-in-asthma-patients-108210 https://curecurrent.com/trials/study-on-foster-efficacy-maintenance-and-reliever-vs-foster-maintenance-salbutamol-reliever-in-asthmatics-mart2-108211 https://curecurrent.com/trials/dual-remission-in-moderate-to-severe-asthma-and-nasal-polyps-108212 https://curecurrent.com/trials/comparative-effects-of-posture-correction-exercises-and-papworth-technique-in-asthmatic-forward-head-posture-108213 https://curecurrent.com/trials/towards-digital-management-of-paediatric-asthma-108214 https://curecurrent.com/trials/phosphodiesterase-4-gene-variant-and-salbutamol-response-in-persistent-childhood-asthma-108215 https://curecurrent.com/trials/creating-a-risk-assessment-tool-for-thunderstorm-asthma-the-carista-study-108216 https://curecurrent.com/trials/early-life-intervention-in-pediatrics-supported-by-e-health-smoke-108217 https://curecurrent.com/trials/real-world-immunogenicity-of-anti-il5-5a-antibody-108218 https://curecurrent.com/trials/ventilation-and-perfusion-in-asthmatics-108219 https://curecurrent.com/trials/asthma-link-effectiveness-trial-108220 https://curecurrent.com/trials/reversibility-of-methacholine-induced-bronchoconstriction-108221 https://curecurrent.com/trials/telehealth-enhanced-asthma-care-for-home-after-the-emergency-room-108222 https://curecurrent.com/trials/mechanisms-of-acute-asthma-exacerbations-through-molecular-analysis-of-airway-secretions-and-tissues-108223 https://curecurrent.com/trials/a-study-to-investigate-the-efficacy-and-safety-of-verekitug-upb-101-in-adult-participants-with-severe-asthma-valiant-108224 https://curecurrent.com/trials/international-severe-asthma-registry-canadian-cohort-108225 https://curecurrent.com/trials/a-trial-of-hbm9378-in-healthy-chinese-subjects-108226 https://curecurrent.com/trials/application-construction-and-effect-evaluation-of-family-empowered-pulmonary-rehabilitation-in-school-age-children-with-108227 https://curecurrent.com/trials/a-culturally-tailored-scalable-asthma-intervention-for-hispanic-children-asthma-guardian-108228 https://curecurrent.com/trials/propulsion-sante-inflammometry-to-improve-the-diagnostic-trajectory-in-situations-of-suspected-asthma-in-children-and-ad-108229 https://curecurrent.com/trials/severe-asthma-network-italy-108230 https://curecurrent.com/trials/promoting-asthma-management-guidelines-with-technology-based-intervention-and-care-coordination-in-clinics-and-schools-108231 https://curecurrent.com/trials/aevicemd-for-pediatric-asthma-management-108232 https://curecurrent.com/trials/a-phase-iii-study-of-cm326-in-subjects-with-moderate-to-severe-asthma-108233 https://curecurrent.com/trials/personalized-approach-to-habits-sleep-108234 https://curecurrent.com/trials/treating-respiratory-emergencies-in-children-study-108235 https://curecurrent.com/trials/role-of-asthma-school-in-disease-management-108236